<?xml version="1.0" encoding="UTF-8"?>
<TEI xml:space="preserve" xmlns="http://www.tei-c.org/ns/1.0" 
xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" 
xsi:schemaLocation="http://www.tei-c.org/ns/1.0 /home/lopez/grobid/grobid-home/schemas/xsd/Grobid.xsd"
 xmlns:xlink="http://www.w3.org/1999/xlink">
	<teiHeader xml:lang="en">
		<fileDesc>
			<titleStmt>
				<title level="a" type="main">Impaired Glucose Tolerance and Insulin Resistance Are Associated With Increased Adipose 11 -Hydroxysteroid Dehydrogenase Type 1 Expression and Elevated Hepatic 5 -Reductase Activity</title>
			</titleStmt>
			<publicationStmt>
				<publisher>American Diabetes Association</publisher>
				<availability status="unknown"><p>Copyright American Diabetes Association</p>
				</availability>
				<date type="published" when="2008-07-15">2008-07-15</date>
			</publicationStmt>
			<sourceDesc>
				<biblStruct>
					<analytic>
						<author role="corresp">
							<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Jeremy</forename><forename type="middle">W</forename><surname>Tomlinson</surname></persName>
							<email>j.w.tomlinson@bham.ac.uk</email>
							<affiliation key="aff0">
								<orgName type="department" key="dep1">Division of Medical Sciences</orgName>
								<orgName type="department" key="dep2">Institute of Biomedical Research</orgName>
								<orgName type="institution" key="instit1">University of Birmingham</orgName>
								<orgName type="institution" key="instit2">Queen Elizabeth Hospital</orgName>
								<address>
									<addrLine>Edgbaston, Birming-ham</addrLine>
									<country key="GB">U.K</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Joanne</forename><surname>Finney</surname></persName>
							<affiliation key="aff1">
								<orgName type="department">Wellcome Trust Clinical Research Facility</orgName>
								<orgName type="institution">University Hospitals Birmingham NHS Foundation Trust</orgName>
								<address>
									<settlement>Birmingham</settlement>
									<country key="GB">U.K</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Christopher</forename><surname>Gay</surname></persName>
							<affiliation key="aff0">
								<orgName type="department" key="dep1">Division of Medical Sciences</orgName>
								<orgName type="department" key="dep2">Institute of Biomedical Research</orgName>
								<orgName type="institution" key="instit1">University of Birmingham</orgName>
								<orgName type="institution" key="instit2">Queen Elizabeth Hospital</orgName>
								<address>
									<addrLine>Edgbaston, Birming-ham</addrLine>
									<country key="GB">U.K</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Beverly</forename><forename type="middle">A</forename><surname>Hughes</surname></persName>
							<affiliation key="aff0">
								<orgName type="department" key="dep1">Division of Medical Sciences</orgName>
								<orgName type="department" key="dep2">Institute of Biomedical Research</orgName>
								<orgName type="institution" key="instit1">University of Birmingham</orgName>
								<orgName type="institution" key="instit2">Queen Elizabeth Hospital</orgName>
								<address>
									<addrLine>Edgbaston, Birming-ham</addrLine>
									<country key="GB">U.K</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Susan</forename><forename type="middle">V</forename><surname>Hughes</surname></persName>
							<affiliation key="aff0">
								<orgName type="department" key="dep1">Division of Medical Sciences</orgName>
								<orgName type="department" key="dep2">Institute of Biomedical Research</orgName>
								<orgName type="institution" key="instit1">University of Birmingham</orgName>
								<orgName type="institution" key="instit2">Queen Elizabeth Hospital</orgName>
								<address>
									<addrLine>Edgbaston, Birming-ham</addrLine>
									<country key="GB">U.K</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Paul</forename><forename type="middle">M</forename><surname>Stewart</surname></persName>
							<affiliation key="aff0">
								<orgName type="department" key="dep1">Division of Medical Sciences</orgName>
								<orgName type="department" key="dep2">Institute of Biomedical Research</orgName>
								<orgName type="institution" key="instit1">University of Birmingham</orgName>
								<orgName type="institution" key="instit2">Queen Elizabeth Hospital</orgName>
								<address>
									<addrLine>Edgbaston, Birming-ham</addrLine>
									<country key="GB">U.K</country>
								</address>
							</affiliation>
						</author>
						<title level="a" type="main">Impaired Glucose Tolerance and Insulin Resistance Are Associated With Increased Adipose 11 -Hydroxysteroid Dehydrogenase Type 1 Expression and Elevated Hepatic 5 -Reductase Activity</title>
					</analytic>
					<monogr>
						<title level="j" type="main">Diabetes</title>
						<title level="j" type="abbrev">Diabetes</title>
						<idno type="ISSN">0012-1797</idno>
						<idno type="eISSN">1939-327X</idno>
						<imprint>
							<publisher>American Diabetes Association</publisher>
							<biblScope unit="volume">57</biblScope>
							<biblScope unit="issue">10</biblScope>
							<biblScope unit="page" from="2652" to="2660"/>
							<date type="published" when="2008-07-15" />
						</imprint>
					</monogr>
					<idno type="DOI">10.2337/db08-0495</idno>
					<idno type="PMID">18633104</idno>
					<idno type="PMCID">PMC2551674</idno>
					<ptr type="open-access" target="http://diabetes.diabetesjournals.org/content/57/10/2652.full.pdf" />
					<note type="submission">Received 11 April 2008 and accepted 30 June 2008.</note>
				</biblStruct>
			</sourceDesc>
		</fileDesc>
		<encodingDesc>
			<appInfo>
				<application version="0.6.2-SNAPSHOT" ident="GROBID" when="2020-08-14T00:32+0000">
					<desc>GROBID - A machine learning software for extracting information from scholarly documents</desc>
					<ref target="https://github.com/kermitt2/grobid"/>
				</application>
			</appInfo>
		</encodingDesc>
		<profileDesc>
			<abstract>
				<p>OBJECTIVE-The precise molecular mechanisms contributing to the development of insulin resistance, impaired glucose tolerance (IGT), and type 2 diabetes are largely unknown. Altered endogenous glucocorticoid metabolism, including 11␤-hydroxysteroid dehydrogenase type 1 (11␤-HSD1), which generates active cortisol from cortisone, and 5␣-reductase (5␣R), which inactivates cortisol, has been implicated. RESEARCH DESIGN AND METHODS-A total of 101 obese patients (mean age 48 Ϯ 7 years, BMI 34.4 Ϯ 4.3 kg/m 2 , 66 women, 35 men) underwent 75-g oral glucose tolerance testing (OGTT), body composition analysis (dual-energy X-ray absorptiometry), assessment of glucocorticoid metabolism (24-h urine steroid metabolite analysis by gas chromatography/mass spectrometry), and subcutaneous abdominal adipose tissue biopsies. RESULTS-A total of 22.7% of women had IGT compared with 34.2% of men. Two women and five men were diagnosed with type 2 diabetes. In women, adipose 11␤-HSD1 expression was increased in patients with IGT and correlated with glucose levels across the OGTT (R ϭ 0.44, P Ͻ 0.001) but was independent of fat mass. Total glucocorticoid secretion was higher in men with and without IGT (normal 13,743 Ϯ 863 vs. 7,453 Ϯ 469 g/24 h,</p>
			</abstract>
		</profileDesc>
	</teiHeader>
	<text xml:lang="en">
		<body>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>D</head><p>espite the severe health consequences of obesity <ref type="bibr" target="#b0">(1)</ref> and the alarming rate at which its prevalence is increasing (2), many questions remain unanswered with regard to its pathogenesis and etiology. Insulin resistance and obesity are tightly associated, yet the molecular mechanisms that underpin this relationship are unknown. Insulin resistance has been implicated as central not only to the development of obesity itself but also its complications, including dyslipidemia, thromboembolic disease, and hypertension <ref type="bibr" target="#b1">(3)</ref>. Furthermore, it is a feature of many other clinical conditions, including polycystic ovary syndrome (PCOS), where the degree of insulin resistance exceeds that observed in body composition-matched control subjects <ref type="bibr" target="#b2">(4)</ref>. The association between insulin resistance and obesity almost certainly explains the dramatic relationship between obesity and type 2 diabetes <ref type="bibr" target="#b3">(5,</ref><ref type="bibr" target="#b4">6)</ref>. Type 2 diabetes evolves from a state of insulin resistance with hyperinsulinema necessary to maintain glucose tolerance. Type 2 diabetes is manifest when insulin secretion fails to meet demands, with consequent hyperglycemia and eventual pancreatic ␤-cell failure. Impaired glucose tolerance (IGT), defined as a 2-h glucose concentration Ͼ7.8 mmol/l but Ͻ11.1 mmol/l after 75-g oral glucose testing (OGTT), significantly increases the risk of progression to type 2 diabetes <ref type="bibr" target="#b5">(7)</ref>, and although rates of progression to type 2 diabetes are variable, they may exceed 10% per year <ref type="bibr" target="#b6">(8,</ref><ref type="bibr" target="#b7">9)</ref>. Although the benefits of lifestyle intervention are clear <ref type="bibr" target="#b7">(9)</ref>, the molecular mechanisms that cause IGT and, similarly, the mechanisms by which IGT progresses to type 2 diabetes are largely unknown.</p><p>The role of endogenous glucocorticoids in the development of obesity and insulin resistance has been widely speculated on based upon observation in patients with glucocorticoid excess (Cushing's syndrome). These patients develop a classical phenotype including central obesity, insulin resistance, and in some cases type 2 diabetes. However, simple obesity and insulin resistance are not caused by subclinical endogenous glucocorticoid excess; circulating cortisol levels in obese patients are not elevated <ref type="bibr" target="#b8">(10)</ref>. Tissue-specific glucocorticoid metabolism, however, may be important. The enzyme 11␤-hydroxysteroid dehydrogenase type 1 (11␤-HSD1) is highly expressed in liver, adipose tissue, and muscle and generates the active glucocorticoid cortisol from inactive cortisone and therefore amplifies local glucocorticoid action <ref type="bibr" target="#b9">(11)</ref>. However, 11␤-HSD1 is a bidirectional enzyme and is capable of inactivating cortisol to cortisone. Critically, the directionality of 11␤-HSD1 activity is cofactor (NADPH) dependent, which is supplied by a tightly associated endolumenal enzyme, hexose-6-phopshate dehydrogenase (H6PDH). Decreases in H6PDH expression and activity decrease oxoreductase and increase dehydrogenase activity <ref type="bibr" target="#b10">(12,</ref><ref type="bibr" target="#b11">13)</ref>. Recently, much attention has focused on pharmacological manipulation of cortisol metabolism as a therapeutic strategy. Selective 11␤-HSD1 inhibitors administered to rodents and primates decrease local glucocorticoid generation, improve glucose tolerance, increase insulin sensitivity, and may promote weight loss <ref type="bibr">(14 -17)</ref>. In contrast to the action of 11␤-HSD1, the A-ring reductases (5␣-reductase type 1 [5␣R1] and type 2 [5␣R2] and 5␤-reductase) inactivate cortisol, decreasing local glucocorticoid availability to bind and activate the glucocorticoid receptor (GR). 5␣R1 is expressed in skin and adipose tissue <ref type="bibr" target="#b16">(18,</ref><ref type="bibr" target="#b17">19)</ref> and 5␣R2 in prostate, epididymis, and seminal vesicles; both isozymes are expressed in the liver <ref type="bibr" target="#b16">(18)</ref>.</p><p>Studies published to date have focused principally on the role of cortisol metabolism in the pathogenesis of obesity rather than that of insulin resistance. We have performed a detailed clinical study in a large cohort of obese patients exploring the concept that cortisol metabolism is an important regulator of insulin sensitivity and that this may be independent of fat mass. We have hypothesized that decreased local glucocorticoid availability (through decreased 11␤-HSD1 and/or increased A-ring reductase activity) will represent a novel physiological adaptive response to preserve insulin sensitivity in a cohort of patients predisposed to the development of insulin resistance, IGT, and type 2 diabetes.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>RESEARCH DESIGN AND METHODS</head><p>The study was approved by the South Birmingham Local Research Ethics Committee, and all subjects gave informed, written consent. A total of 101 obese volunteers (35 male, 66 female, mean age Ϯ SD 48 Ϯ 7 years, mean BMI 34.4 Ϯ 4.3 kg/m 2 ) were recruited following local advertisement and underwent the clinical protocol described below. Patients had no significant past medical history, and none had received glucocorticoid therapy (oral, topical, or inhaled) within the last 12 months. All patients had normal blood counts and renal function.</p><p>Subjects were investigated in the fasting state. Blood samples were drawn at 9 A.M. for measurement of total cholesterol, triglycerides, cortisol, cortisone, glucose, insulin, and A1C. Measurements of BMI, waist circumference (measured supine, at the level of the umbilicus), hip circumference (at the level of the greater trochanter), and blood pressure (average of three readings, measured supine after 10 min rest using Dynamap [Critikon, Tampa, FL]) were also taken. Patients underwent a standard 75-g oral glucose tolerance test, with samples taken at 30-min intervals for 120 min for measurement of insulin and glucose.</p><p>In the fasting state, all patients had an abdominal subcutaneous adipose tissue biopsy (10 -15 cm lateral to the umbilicus) performed under local anesthetic (1-2 ml of 1% lidocaine) in order to obtain ϳ250 -500 mg of adipose tissue. The sample was immediately placed in RNALater (Ambion, Austin, TX) and, after initial storage for 24 h at room temperature, was stored at Ϫ20°C for subsequent total RNA extraction, reverse transcription, and real-time PCR analysis.</p><p>In addition, all patients performed a 24-h urine collection for corticosteroid metabolite analysis <ref type="bibr" target="#b18">(20)</ref>. Body composition analysis was performed using dual-energy X-ray absorptiometry (DEXA) with a total body scanner (QDR 45OO; Hologic, Bedford, MA). Coefficients of variation (CVs) for multiple scans were Ͻ3%. Regional fat mass (trunk and leg) was analyzed as previously described <ref type="bibr" target="#b19">(21)</ref>. Biochemical assays. Blood counts, urea, creatinine and electrolytes, cholesterol, triglycerides, liver chemistry, glucose, and A1C were measured using standard laboratory methods (Roche Modular system; Roche, Lewes, U.K.). Insulin was measured using a commercially available colorimetric ELISA (Mercodia, Uppsala, Sweden) with an in-house CV of Ͻ5%. Cortisol was measured using a coat-a-count radioimmunoassay (Diagnostic Products, Los Angeles, CA) as per the manufacturer's guidelines. Cortisone was assayed after extraction from serum followed by radioimmunoassay of the extract with 125 I-cortisone and Sac-Cel (IDS, Tyne and Weir, U.K.) second antibody separation <ref type="bibr" target="#b20">(22)</ref>. The CV for 10 consecutive assays was Ͻ15% for values between 50 and 100 nmol/l and Ͻ10% for values over 100 nmol/l. Calculated measures of pancreatic ␤-cell function and insulin resistance were made using the homeostasis model assessment (HOMA) 2 model <ref type="bibr" target="#b21">(23)</ref>. The HOMA of ␤-cell function (HOMA %B) values provide an index of pancreatic islet ␤-cell function relative to a normal individual with a value set at 100%. Similarly, HOMA of insulin sensitivity (HOMA %S) values represent a measure of insulin sensitivity relative to a normal individual, again with a value of 100%. The HOMA of insulin resistance is a reciprocal measure of the %S values. Urinary corticosteroid metabolites. Urinary corticosteroid metabolite analysis was performed by gas chromatography/mass spectrometry (GC/MS) as described previously <ref type="bibr" target="#b18">(20)</ref>. The sum of total cortisol metabolites (tetrahydrocortisol [THF ], tetrahydrocortisone [THE], 5␣-THF, ␣-cortolone, cortisone [E], cortisol [F], ␤-cortolone, ␤-cortol, and ␣-cortol) provides a reflection of cortisol secretion rate. The ratio of tetrahydrometabolites of cortisol (THF ϩ 5␣THF) to those of cortisone (THE) provides a reflection of 11␤-HSD1 activity when considered with the ratio of urinary free cortisol to cortisone, which more accurately reflects renal 11␤-HSD2 activity <ref type="bibr" target="#b18">(20)</ref>. The ratios of cortols to cortolones and of 11␤-hydroxy-etiocholanolone and 11␤-hydroxy-androsterone combined to 11oxo-etiocholanolone also reflect 11␤-HSD1 activity <ref type="bibr" target="#b22">(24)</ref>. The activities of 5␣-and 5␤-reductases can be inferred from measuring the ratio of 5␣ THF to THF and androsterone to etiocholanolone. RNA extraction and reverse transcription. Following subcutaneous adipose tissue biopsy, total RNA was extracted using a single-step extraction method (Magmax 96; Applied Biosystems, Foster City, CA) as per the manufacturer's guidelines. RNA integrity and quantity were assessed using a Nanodrop spectrophotometer (Wilmington, DE).</p><p>One microgram of total RNA was initially denatured by heating to 70°C for 5 min. Thirty units of avian myeloblastososis virus, 200 ng of random primers, 20 units of ribonuclease inhibitor, and 40 nmol of deoxy-nucleoside triphosphates with 5ϫ reaction buffer were added to the RNA, and the reverse transcriptase reaction was carried out at 37°C for 1 h. The reaction was terminated by heating the cDNA to 95°C for 5 min. Real-time PCR. mRNA levels of genes of interest were determined using an ABI 7500 sequence detection system (Perkin-Elmer and Applied Biosystems, Warrington, U.K.). Reactions were performed in 25-l volumes on 96-well plates in reaction buffer containing 2ϫ TaqMan Universal PCR Master mix (Applied Biosystems, Foster City, CA). Probes and primers for all genes were supplied by assay on demand (Applied Biosystems). All reactions were normalized against the housekeeping gene 18S rRNA, provided as a preoptimized control probe.</p><p>Data were measured as the cycle number at which logarithmic PCR plots cross a calculated threshold line (CT) and used to determine ⌬CT values [(⌬CT of the target gene) Ϫ (⌬CT of the housekeeping gene). Data were expressed as arbitrary units (AU) using the following transformation: expression ϭ 10 5 ϫ (2 Ϫ⌬CT ) AU. Statistical analysis. Data are presented as means Ϯ SE unless otherwise stated. Area under the curve (AUC) analysis was performed using the trapezoidal method. For comparison of single variables, t tests have been used (or nonparametric equivalents where data were not normally distributed). Regression analyses were performed using Pearson correlations; where more than one variable was considered, multiple linear regression analysis was used. All analysis was performed using SigmaStat 3.1 (Systat Software, Point Richmond, CA).</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>RESULTS</head><p>A total of 101 (66 women and 35 men) volunteers were recruited into the study; 48 women (72.7%) and 17 men (48.6%) had normal fasting glucose levels and normal glucose tolerance. Two women (3.0%) and three men A1C was increased in both men and women with IGT, although this only reached statistical significance in men (men 5.3 Ϯ 0.1 vs. 5.9 Ϯ 0.3%, P Ͻ 0.05; women 5.4 Ϯ 0.1 vs. 5.7 Ϯ 0.1%, P ϭ 0.08). Surprisingly, measures of insulin resistance (HOMA-R, fasting and 2-h insulin concentrations) were not different between groups <ref type="table" target="#tab_0">(Table 1)</ref>. Furthermore, body composition analysis by DEXA failed to show differences in fat-free mass or total or regional fat mass between those patients with normal glucose tolerance or IGT <ref type="table" target="#tab_0">(Table 1)</ref>. Although men and women were not different in terms of insulin resistance (as measured by HOMA, fasting insulin, 2-h insulin or insulin AUC across the 75-g OGTT, percent trunk fat and absolute total and trunk fat mass were higher in women with correspondingly lower fat-free masses <ref type="table" target="#tab_0">(Table 1)</ref>.</p><p>Urinary steroid metabolite analysis by GC/MS demonstrated clear sexual dimorphism with increased total and individual glucocorticoid metabolite production rates in men compared with women for subjects with and without IGT <ref type="table" target="#tab_1">(Table 2)</ref>. When analyzed according to glucose tolerance, total glucocorticoid production rates were higher in women with IGT compared with women with normal glucose tolerance (10,133 Ϯ 1,488 vs. 7,453 Ϯ 469, respectively, P Ͻ 0.05), but this relationship was not observed in men (16,871 Ϯ 2,113 vs. 13,743 Ϯ 863, respectively, P ϭ 0.17). Furthermore, there were no differences in absolute production rates for individual metabolites or activities of metabolizing enzymes (in particular 11␤-HSD1 or 5␣R) when comparing normal and IGT subjects <ref type="table" target="#tab_1">(Table 2)</ref>. Adipose tissue biopsy gene expression. Successful isolation of total RNA and generation of cDNA from subcutaneous adipose tissue biopsies was achieved in 90 volunteers. All samples expressed 11␤-HSD1, H6PDH, GR, and 5␣R1. In contrast, 5␣R2 was only expressed in 5 of 90 samples and only at very low levels (data not shown).</p><p>Whereas 11␤-HSD1, GR, and 5␣R1 mRNA expression levels were similar in men and women, H6PDH expression was higher in biopsies from male volunteers (2.3 Ϯ 0.4 vs. 1.6 Ϯ 0.5 AU, P Ͻ 0.05).</p><p>In women only, adipose tissue 11␤-HSD1 expression was higher in those with IGT than in those with normal glucose tolerance (0.5 Ϯ 0.06 vs. 0.29 Ϯ 0.03 AU, P Ͻ 0.005), despite fat mass (total and regional) being similar between the two groups <ref type="figure" target="#fig_0">(Fig. 1A)</ref>. Moreover, expression correlated with glucose AUC across the OGTT (R ϭ 0.44, P Ͻ 0.005) <ref type="figure" target="#fig_0">(Fig. 1B)</ref> but not with fat mass (total fat mass R ϭ 0.12, P ϭ NS; trunk fat mass R ϭ 0.15, P ϭ NS). H6PDH expression was lower in female volunteers with IGT (0.79 Ϯ 0.1 vs. 1.38 Ϯ 0.14 AU, P Ͻ 0.05), but GR and 5␣R1 expression did not differ <ref type="figure" target="#fig_0">(Fig. 1A)</ref>. In contrast to our findings in women, expression of 11␤-HSD1, H6PDH, GR, and 5␣R1 in adipose tissue biopsies from men did not differ between those with and those without IGT and did not relate to glucose levels across an OGTT <ref type="figure" target="#fig_0">(Fig. 1C  and D)</ref>. Regression analyses. Univariate regression analysis revealed positive relationships between 5␣R activity (as measured by both the urinary androsterone-to-etiocholanolone and 5␣THF-to-THF ratios) and markers of insulin resistance. In women, significant correlations were observed with fasting insulin, 2-h insulin levels after 75 g oral glucose, AUC insulin across the OGTT, and HOMA-R <ref type="table" target="#tab_2">(Table 3</ref> and <ref type="figure" target="#fig_1">Fig. 2A-D)</ref>. In men, a similar pattern was observed <ref type="table" target="#tab_2">(Table 3</ref>; <ref type="figure" target="#fig_1">Fig. 2A-D)</ref>, but in addition, increased 5␣R activity was associated with decreased pancreatic ␤-cell function as calculated from the HOMA-%B ( <ref type="table" target="#tab_2">Table 3)</ref>. Activity of 5␣R increased with increasing total and regional fat and fat-free mass in men but not in women <ref type="table" target="#tab_2">(Table 3)</ref>. While these relationships remained significant, they were weaker than those observed with markers of insulin resistance. There was no relationship in either sex with fat distribution as measured by waist circumference, WHR, or the trunk fat-to-limb fat ratio via DEXA.</p><p>Total glucocorticoid secretion rate increased with total and regional fat and fat-free mass in women but not in men and was weakly associated with 2-h insulin concentration after 75 g oral glucose <ref type="table" target="#tab_3">(Table 4</ref>). Global 11␤-HSD1 activity as measured by the 5␣ THF ϩ THF-to-THE ratio was unrelated to metabolic or anthropometric variables in women and only weakly related to HOMA-R in men (R ϭ 0.38, P ϭ 0.04). 11␤-HSD2 inactivates cortisol to cortisone in mineralocorticoid target tissues, notably the kidney. Activity is reflected in the ratio of urinary free cortisol to cortisone. This was unrelated to metabolic parameters with the exception of 2-h insulin levels in men only (R ϭ 0.389, P ϭ 0.03) and inversely related to WHR in women only (R ϭ Ϫ0.30, P ϭ 0.04).</p><p>Using multivariate modeling to correct for total and regional fat mass, 5␣R activity remained an independent predictor of insulin secretion across the OGTT (2-h insulin P Ͻ 0.005; insulin AUC P Ͻ 0.005) in women. In men, 5␣R activity and not fat mass independently predicted fasting insulin levels (P Ͻ 0.05), HOMA-%B (P Ͻ 0.05), HOMA-%S (P Ͻ 0.05), and HOMA-R (P Ͻ 0.05).</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>DISCUSSION</head><p>In this unselected cohort of obese patients, we have identified the prevalence of IGT to be 22.7% in women and 34.2% in men and the prevalence of type 2 diabetes to be 3.0% in women and 14.3% in men. This was associated with central fat distribution (but not absolute fat mass) in women and unrelated to fat mass or distribution in men.</p><p>In this cohort, subcutaneous adipose tissue 11␤-HSD1 mRNA expression was higher in women with IGT and correlated with glucose secretion across the OGTT but was unrelated to fat mass, consistent with our previous observations <ref type="bibr" target="#b23">(25)</ref>. Previous studies have examined 11␤-HSD1 mRNA expression and activity in adipose tissue in the context of fat mass with variable results. Within the subcutaneous depot, most studies, although not all, have suggested increased expression with indexes of obesity <ref type="bibr" target="#b23">(25)</ref><ref type="bibr" target="#b24">(26)</ref><ref type="bibr" target="#b25">(27)</ref><ref type="bibr" target="#b26">(28)</ref><ref type="bibr" target="#b27">(29)</ref>, but relative expression within the intra-abdominal depot remains controversial. Importantly, the expression of 11␤-HSD1 in adipose tissue and its relationship with insulin resistance and glucose tolerance has not been examined before. While expression studies were only performed in subcutaneous adipose tissue, enhanced cortisol generation through increased 11␤-HSD1 mRNA expression may contribute to glucose intolerance through increased lipolysis <ref type="bibr" target="#b28">(30,</ref><ref type="bibr" target="#b29">31)</ref> and generation of free fatty acids, which impair peripheral glucose uptake <ref type="bibr" target="#b30">(32)</ref>. However, due to the small volumes of tissue obtained, activity studies were not performed and it is possible that decreased H6PDH expression that we also observed in the IGT group may decrease 11␤-HSD1 oxo-reductase activity by limiting cofactor supply. Sexually dimorphic activity and expression of 11␤-HSD1 has been described in some studies <ref type="bibr" target="#b31">(33)</ref> but not all <ref type="bibr" target="#b32">(34)</ref>. In our cohort, urinary GC/MS analysis was similar in men and women. Studies examining sex-specific regulation of expression within adipose tissue are lacking. In nonadipose tissue, estradiol has been shown to regulate expression levels, and it is possible that this may contribute to our observations; however, the published data are often contradictory with studies showing both increased and decreased expression <ref type="bibr" target="#b33">(35)</ref><ref type="bibr" target="#b34">(36)</ref><ref type="bibr" target="#b35">(37)</ref><ref type="bibr" target="#b36">(38)</ref>. With the exception of dehydroepiandrosterone <ref type="bibr" target="#b37">(39)</ref>, there is little evidence to support a role for regulation by androgens <ref type="bibr" target="#b33">(35,</ref><ref type="bibr" target="#b36">38)</ref>. Sexually dimorphic expression of H6PDH has not been described previously, and the observed increase in expression in men will need to be endorsed with dedicated activity studies to see if changes in H6PDH expression translate into alterations in glucocorticoid availability. However, it is possible that this could contribute to differences in fat distribution between men and women, with the consequent increase in cardiovascular risk <ref type="bibr" target="#b38">(40)</ref>.</p><p>In our study, in both sexes, 5␣R activity as measured by urinary glucocorticoid metabolite ratios increased with indexes of insulin resistance, an observation that was independent of fat mass. The role of 5␣R in the control of body composition and insulin sensitivity has not been explored in detail in the published literature. The global measures of activity that we have used in this study do not allow us to distinguish between 5␣R1 and 5␣R2, and whereas patients with 5␣R2 mutations have clear evidence of abnormal hepatic cortisol metabolism (41), the contribution of 5␣R1 is yet to be clarified. Sexual dimorphism of 5␣R activity has been described with increased activity in male subjects <ref type="bibr" target="#b8">(10,</ref><ref type="bibr" target="#b32">34)</ref>. In our study, absolute levels of 5␣and 5␤-reduced metabolites were higher in men (as was total glucocorticoid production rate), but the relative balance of 5␣R and 5␤R activity was not different. Furthermore, 5␣R1 mRNA expression in subcutaneous adipose tissue was similar in men and women. Studies in small cohorts of patients have shown enhanced 5␣R activity with obesity (42) and type 2 diabetes <ref type="bibr" target="#b41">(43)</ref> and regulation of 5␣R and 5␤R activity by dietary macronutrient composition; high-fat, low-carbohydrate and moderate-fat, moderate-carbohydrate diets decrease 5␣R and 5␤R activity in the context of weight loss <ref type="bibr" target="#b42">(44)</ref>. Thiazolidinedione treatment of obese Zü cker rats decreases 5␣R1 expression in the liver <ref type="bibr" target="#b43">(45)</ref>, but similar experiments in humans have not been performed. However, we have recently shown that following weight loss with consequent insulin sensitization, 5␣R activity decreased <ref type="bibr" target="#b44">(46)</ref>. 5␣R has been implicated in the pathogenesis of the insulin resistance associated with PCOS, in that patients with PCOS are more insulin resistant compared with body composition-matched control subjects (4) and have increased 5␣R activity <ref type="bibr" target="#b45">(47)</ref>. Moreover, within a cohort of patients with PCOS, 5␣R activity correlates with insulin resistance <ref type="bibr" target="#b46">(48)</ref>. Our findings are consistent with these data and extend this observation to healthy obese women and men, as well as demonstrate that the relationship (in both sexes) is independent of fat mass. In the context of insulin resistance, we postulate that increased 5␣R activity represents a compensatory mechanism to decrease local glucocorticoid availability and occurs in conjunction with the decrease in 11␤-HSD1 activity (as evidenced by reduced cortisol generation following oral cortisone administration and decreased urinary 5␣-ϩ THF-to-THE ratios) that we and others have previously described in obesity <ref type="bibr" target="#b20">(22,</ref><ref type="bibr" target="#b24">26)</ref>. These processes act together (decreased generation of cortisol through a reduction in 11␤-HSD1 and increased inactivation of cortisol through enhanced 5␣R activity) to decrease local glucocorticoid availability and decrease GR activation specifically within the liver, with the aim of maintenance of hepatic insulin sensitivity. A further impact of these changes will be to drive the hypothalamo-pituitary-adrenal axis in order to maintain circulating cortisol levels. While we believe that the changes that we have observed largely reflect hepatic glucocorticoid metabolism, a direct effect upon insulin secretion cannot be excluded. However, this remains highly speculative, bearing in mind that evidence of A-ring reductase expression in human pancreatic islets is lacking. Pharmacological manipulation of glucocorticoid availability through prereceptor metabolism adds credence to our observations. Selective 11␤-HSD1 inhibitors that decrease local glucocorticoid availability remain an exciting therapeutic prospect. Significant improvements in insulin sensitivity, glucose tolerance, and lipid profiles following short-term administration in rodents and primates have been observed. Human clinical studies are still eagerly awaited. Conversely, Finasteride (5␣R2 inhibitor) and Dutasteride (combined 5␣R1 and 5␣R2 inhibitor) are widely used in the treatment of prostatic hypertrophy <ref type="bibr" target="#b47">(49)</ref> based upon their action upon androgen metabolism. However, by decreasing glucocorticoid inactivation, they may have a detrimental impact upon insulin sensitivity, but the studies to address this question have not been performed.</p><p>In conclusion, this study adds to the growing body of evidence that supports a role for 5␣R in the control of insulin sensitivity in simple obesity. While little is currently known about the regulation of 5␣R activity, limiting local glucocorticoid availability through enhanced 5␣R and/or inhibition of 11␤-HSD1 activity may have significant clinical benefits. Finally, prospective studies examining the changes in activity and expression of these enzymes over time may begin to shed light on their potential role in the development of IGT and type 2 diabetes. </p></div><figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_0"><head>FIG. 1 .</head><label>1</label><figDesc>In women only, IGT is associated with increased adipose tissue 11␤-HSD1 but decreased H6PDH mRNA expression (A) without alteration in fat mass; 11␤-HSD1 mRNA levels correlate with glucose AUC across an OGTT (B). However, in men with IGT, adipose 11␤-HSD1, H6PDH, GR, and 5␣R1 mRNA expression is not dysregulated (C and D). Ⅺ, normal glucose tolerance; f, IGT.</figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_1"><head>FIG. 2 .</head><label>2</label><figDesc>Increasing 5␣-reductase activity is associated with increased insulin secretion across an OGTT in men (F) and women (Ⅺ)-fasting insulin (A), 2-h insulin (B), area under curve insulin (C), and increased insulin resistance as measured by HOMA-IR (D).</figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_0"><head>TABLE 1</head><label>1</label><figDesc>Clinical and serum biochemical characteristics of obese men and women with normal or IGT</figDesc><table><row><cell></cell><cell></cell><cell>Women</cell><cell></cell><cell></cell><cell>Men</cell><cell></cell></row><row><cell></cell><cell>Normal</cell><cell>IGT</cell><cell>P</cell><cell>Normal</cell><cell>IGT</cell><cell>P</cell></row><row><cell>n</cell><cell>48</cell><cell>15</cell><cell></cell><cell>17</cell><cell>12</cell><cell></cell></row><row><cell>Age (years)</cell><cell>48 Ϯ 7</cell><cell>4 6Ϯ 8</cell><cell>0.39</cell><cell>48 Ϯ 8</cell><cell>5 3 Ϯ 8</cell><cell>0.11</cell></row><row><cell>Systolic blood pressure (mmHg)</cell><cell>124 Ϯ 17</cell><cell>127 Ϯ 12</cell><cell>0.52</cell><cell>135 Ϯ 16*</cell><cell>139 Ϯ 22</cell><cell>0.60</cell></row><row><cell>Diastolic blood pressure (mmHg)</cell><cell>72 Ϯ 11</cell><cell>76 Ϯ 12</cell><cell>0.28</cell><cell>80 Ϯ 14*</cell><cell>79 Ϯ 10</cell><cell>0.88</cell></row><row><cell>Anthropometry</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>BMI (kg/m 2 )</cell><cell>34.3 Ϯ 4.4</cell><cell>36.4 Ϯ 3.8</cell><cell>0.09</cell><cell>33.4 Ϯ 5.1</cell><cell>34.7 Ϯ 3.9</cell><cell>0.47</cell></row><row><cell>Waist circumference (cm)</cell><cell>103 Ϯ 9.0</cell><cell>111 Ϯ 9</cell><cell>0.002</cell><cell>114 Ϯ 13</cell><cell>116 Ϯ 10</cell><cell>0.57</cell></row><row><cell>WHR</cell><cell>0.87 Ϯ 0.05</cell><cell>0.90 Ϯ 0.05</cell><cell>0.05</cell><cell>0.98 Ϯ 0.07 †</cell><cell>0.99 Ϯ 0.04 †</cell><cell>0.46</cell></row><row><cell>Serum biochemistry</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>Fasting glucose (mmol/l)</cell><cell>4.6 Ϯ 0.6</cell><cell>5.0 Ϯ 0.4</cell><cell>0.02</cell><cell>4.8 Ϯ 0.5</cell><cell>5.4 Ϯ 0.6*</cell><cell>0.009</cell></row><row><cell>2-h glucose (mmol/l)</cell><cell>6.0 Ϯ 1.0</cell><cell>8.8 Ϯ 0.9</cell><cell>Ͻ0.001</cell><cell>5.4 Ϯ 1.4*</cell><cell>9.2 Ϯ 1.5</cell><cell>Ͻ0.001</cell></row><row><cell>Fasting insulin (IU/l)</cell><cell>10.0 Ϯ 7.2</cell><cell>12.3 Ϯ 6.3</cell><cell>0.27</cell><cell>8.7 Ϯ 3.9</cell><cell>12.1 Ϯ 7.2</cell><cell>0.12</cell></row><row><cell>2-h insulin (IU/l) AUC insulin (IU ⅐ l Ϫ1 ⅐ h Ϫ1 )</cell><cell>97.8 Ϯ 66.0 167.6 Ϯ 91.8</cell><cell>128 Ϯ 58.0 173.7 Ϯ 67.6</cell><cell>0.12 0.81</cell><cell>52.0 Ϯ 40.9* 162.6 Ϯ 75.5</cell><cell>97.6 Ϯ 56.7 158.9 Ϯ 107.6</cell><cell>0.02 0.92</cell></row><row><cell>A1C (%)</cell><cell>5.4 Ϯ 0.5</cell><cell>5.7 Ϯ 0.4</cell><cell>0.08</cell><cell>5.3 Ϯ 0.3</cell><cell>5.9 Ϯ 0.9</cell><cell>0.03</cell></row><row><cell>HOMA-%B</cell><cell>141.6 Ϯ 52.2</cell><cell>143.5 Ϯ 52.6</cell><cell>0.90</cell><cell>119.2 Ϯ 32.6</cell><cell>118.9 Ϯ 44.9</cell><cell>0.98</cell></row><row><cell>HOMA-%S</cell><cell>104.6 Ϯ 71.5</cell><cell>78.2 Ϯ 61.8</cell><cell>0.20</cell><cell>101.5 Ϯ 60.1</cell><cell>75.7 Ϯ 42.1</cell><cell>0.20</cell></row><row><cell>HOMA-R</cell><cell>1.5 Ϯ 1.0</cell><cell>1.8 Ϯ 0.9</cell><cell>0.25</cell><cell>1.3 Ϯ 0.6</cell><cell>1.3 Ϯ 1.1</cell><cell>0.10</cell></row><row><cell>Total cholesterol (mmol/l)</cell><cell>5.0 Ϯ 1.0</cell><cell>5.3 Ϯ 1.0</cell><cell>0.29</cell><cell>5.3 Ϯ 0.9</cell><cell>5.0 Ϯ 0.7</cell><cell>0.48</cell></row><row><cell>Triglycerides (mmol/l)</cell><cell>1.3 Ϯ 0.6</cell><cell>1.6 Ϯ 0.6</cell><cell>0.11</cell><cell>2.0 Ϯ 1.8*</cell><cell>1.7 Ϯ 0.8</cell><cell>0.57</cell></row><row><cell>Cortisol (nmol/l)</cell><cell>216 Ϯ 103</cell><cell>204 Ϯ 102</cell><cell>0.70</cell><cell>320 Ϯ 163 ‡</cell><cell>239 Ϯ 80</cell><cell>0.12</cell></row><row><cell>Cortisone (nmol/l)</cell><cell>64 Ϯ 26</cell><cell>55 Ϯ 22</cell><cell>0.30</cell><cell>66 Ϯ 20</cell><cell>73 Ϯ 19*</cell><cell>0.42</cell></row><row><cell>Body composition (DEXA)</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>Trunk fat mass (kg)</cell><cell>19.5 Ϯ 5.0</cell><cell>21.7 Ϯ 4.3</cell><cell>0.14</cell><cell>16.8 Ϯ 4.7</cell><cell>19.2 Ϯ 4.8</cell><cell>0.22</cell></row><row><cell>Trunk fat-free mass (kg)</cell><cell>25.2 Ϯ 3.2</cell><cell>26.1 Ϯ 4.3</cell><cell>0.39</cell><cell>34.6 Ϯ 4.4 †</cell><cell>35.7 Ϯ 3.9 †</cell><cell>0.50</cell></row><row><cell>Total fat mass (kg)</cell><cell>38.8 Ϯ 9.2</cell><cell>41.7 Ϯ 9.3</cell><cell>0.30</cell><cell>29.9 Ϯ 7.7 †</cell><cell>34.4 Ϯ 8.9 ‡</cell><cell>0.17</cell></row><row><cell>Total fat-free mass (kg)</cell><cell>48.6 Ϯ 5.7</cell><cell>50.2 Ϯ 8.4</cell><cell>0.39</cell><cell>66.9 Ϯ 8.1 †</cell><cell>68.7 Ϯ 7.3 †</cell><cell>0.54</cell></row><row><cell>Total % fat</cell><cell>43.0 Ϯ 4.3</cell><cell>44.1 Ϯ 5.0</cell><cell>0.41</cell><cell>29.7 Ϯ 4.2 †</cell><cell>32.2 Ϯ 5.6 †</cell><cell>0.21</cell></row><row><cell>Trunk fat-to-limb fat ratio</cell><cell>1.1 Ϯ 0.2</cell><cell>1.2 Ϯ 0.3</cell><cell>0.09</cell><cell>1.4 Ϯ 0.14 †</cell><cell>1.4 Ϯ 0.23</cell><cell>0.71</cell></row></table><note>Data are means Ϯ SD unless otherwise indicated. *P Ͻ 0.05; †P Ͻ 0.0001; ‡P Ͻ 0.01 vs. women.</note></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_1"><head>TABLE 2</head><label>2</label><figDesc>Urinary corticosteroid metabolite analysis performed by GC/MS on 24-h urine samples from 73 obese volunteers divided by sex and glucose tolerance</figDesc><table><row><cell></cell><cell>Women</cell><cell></cell><cell>Men</cell><cell></cell><cell></cell></row><row><cell>Normal</cell><cell>IGT</cell><cell>P</cell><cell>Normal</cell><cell>IGT</cell><cell>P</cell></row></table><note>Data are means Ϯ SD. UFF, urinary free cortisol; UFE, urinary free cortisone; 11OH-and, 11hydroxyandrosterone; 11OH-etio, 11hydroxye- tiocholanolone; 11oxo-etio, 11oxo-etiocholanolone; Fm, cortisol ϩ THF ϩ 5␣THF ϩ ␣-cortol ϩ ␤-cortol; Em, cortisone ϩ THE ϩ ␣-cortolone ϩ ␤-cortolone. *P Ͻ 0.0001; †P Ͻ 0.05; ‡P Ͻ 0.01 vs. women.(8.6%) had impaired fasting glucose (IFG) (Ͼ5.6 mmol/l), and within this group, two men and no women had IGT. IGT with normal fasting glucose concentrations was ob- served in 15 women (22.7%) and 10 men (28.6%). Type 2 diabetes was diagnosed in two women (3.0%) and five men (14.3%), and all subjects with type 2 diabetes had IFG. Taking into account the sexual dimorphism described in body composition and glucocorticoid metabolite produc- tion rates, subsequent analysis was performed separately in men and women. Normal glucose tolerance versus IGT and IFG. IGT was associated with increased waist circumference (103 Ϯ 1.3 vs. 111 Ϯ 2 cm, P Ͻ 0.002) and waist-to-hip ratio (WHR) (0.87 Ϯ 0.01 vs. 0.90 Ϯ 0.01, P Ͻ 0.05) in women but not in men (waist circumference 114 Ϯ 3 vs. 116 Ϯ 3 cm, P ϭ 0.57; WHR 0.98 Ϯ 0.02 vs. 0.99 Ϯ 0.01, P ϭ 0.46).</note></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_2"><head>TABLE 3</head><label>3</label><figDesc>Correlation of metabolic parameters with 5␣-reductase activity as assessed by the urinary 5␣THF-to-THF and androsterone-toetiocholanolone ratios analyzed by GC/MS</figDesc><table><row><cell></cell><cell></cell><cell cols="2">Women (n ϭ 49)</cell><cell></cell><cell></cell><cell cols="2">Men (n ϭ 30)</cell><cell></cell></row><row><cell></cell><cell cols="2">Androsterone-to-</cell><cell></cell><cell></cell><cell cols="2">Androsterone-to-</cell><cell></cell><cell></cell></row><row><cell></cell><cell cols="2">etiocholanolone ratio</cell><cell cols="2">5␣THF-to-THF ratio</cell><cell cols="2">etiocholanolone ratio</cell><cell cols="2">5␣THF-to-THF ratio</cell></row><row><cell></cell><cell>Correlation</cell><cell></cell><cell>Correlation</cell><cell></cell><cell>Correlation</cell><cell></cell><cell>Correlation</cell><cell></cell></row><row><cell></cell><cell>coefficient (R)</cell><cell>P</cell><cell>coefficient (R)</cell><cell>P</cell><cell>coefficient (R)</cell><cell>P</cell><cell>coefficient (R)</cell><cell>P</cell></row><row><cell>Insulin sensitivity and glucose</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>tolerance</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>Fasting glucose</cell><cell>0.082</cell><cell>0.58</cell><cell>0.065</cell><cell>0.66</cell><cell>0.26</cell><cell>0.17</cell><cell>0.22</cell><cell>0.26</cell></row><row><cell>2-h glucose</cell><cell>0.14</cell><cell>0.35</cell><cell>0.13</cell><cell>0.37</cell><cell>0.13</cell><cell>0.51</cell><cell>0.81</cell><cell>0.67</cell></row><row><cell>Fasting insulin</cell><cell>0.33</cell><cell>0.022</cell><cell>0.27</cell><cell>0.07</cell><cell>0.53</cell><cell>0.003</cell><cell>0.50</cell><cell>0.006</cell></row><row><cell>2-h insulin</cell><cell>0.51</cell><cell>0.0002</cell><cell>0.51</cell><cell>0.0002</cell><cell>0.14</cell><cell>0.48</cell><cell>0.35</cell><cell>0.06</cell></row><row><cell>AUC insulin</cell><cell>0.38</cell><cell>0.007</cell><cell>0.40</cell><cell>0.004</cell><cell>0.31</cell><cell>0.10</cell><cell>0.46</cell><cell>0.01</cell></row><row><cell>A1C</cell><cell>Ϫ0.11</cell><cell>0.47</cell><cell>Ϫ0.09</cell><cell>0.58</cell><cell>0.39</cell><cell>0.04</cell><cell>0.14</cell><cell>0.47</cell></row><row><cell>HOMA-%B</cell><cell>0.26</cell><cell>0.07</cell><cell>0.22</cell><cell>0.13</cell><cell>0.47</cell><cell>0.01</cell><cell>0.55</cell><cell>0.003</cell></row><row><cell>HOMA-%S</cell><cell>Ϫ0.27</cell><cell>0.06</cell><cell>Ϫ0.23</cell><cell>0.11</cell><cell>Ϫ0.43</cell><cell>0.02</cell><cell>Ϫ0.53</cell><cell>0.003</cell></row><row><cell>HOMA-R</cell><cell>0.33</cell><cell>0.02</cell><cell>0.26</cell><cell>0.07</cell><cell>0.52</cell><cell>0.004</cell><cell>0.49</cell><cell>0.008</cell></row><row><cell>Anthropometry</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>BMI</cell><cell>0.14</cell><cell>0.35</cell><cell>Ϫ0.02</cell><cell>0.87</cell><cell>0.28</cell><cell>0.13</cell><cell>0.32</cell><cell>0.08</cell></row><row><cell>Waist circumference</cell><cell>0.15</cell><cell>0.33</cell><cell>0.02</cell><cell>0.90</cell><cell>0.03</cell><cell>0.89</cell><cell>0.14</cell><cell>0.46</cell></row><row><cell>WHR</cell><cell>0.09</cell><cell>0.56</cell><cell>0.16</cell><cell>0.27</cell><cell>0.09</cell><cell>0.62</cell><cell>0.05</cell><cell>0.81</cell></row><row><cell>Body composition (DEXA)</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>Trunk fat mass</cell><cell>0.06</cell><cell>0.67</cell><cell>Ϫ0.04</cell><cell>0.78</cell><cell>0.44</cell><cell>0.02</cell><cell>0.46</cell><cell>0.01</cell></row><row><cell>Trunk fat-free mass</cell><cell>0.11</cell><cell>0.45</cell><cell>Ϫ0.006</cell><cell>0.97</cell><cell>0.41</cell><cell>0.03</cell><cell>0.41</cell><cell>0.03</cell></row><row><cell>Total fat mass</cell><cell>0.02</cell><cell>0.90</cell><cell>Ϫ0.10</cell><cell>0.51</cell><cell>0.36</cell><cell>0.06</cell><cell>0.38</cell><cell>0.04</cell></row><row><cell>Total fat-free mass</cell><cell>0.09</cell><cell>0.56</cell><cell>Ϫ0.02</cell><cell>0.87</cell><cell>0.493</cell><cell>0.008</cell><cell>0.43</cell><cell>0.02</cell></row><row><cell>Total % fat</cell><cell>Ϫ0.02</cell><cell>0.89</cell><cell>Ϫ0.07</cell><cell>0.62</cell><cell>0.18</cell><cell>0.37</cell><cell>0.24</cell><cell>0.23</cell></row><row><cell>Trunk fat-to-limb fat ratio</cell><cell>0.10</cell><cell>0.51</cell><cell>0.10</cell><cell>0.52</cell><cell>0.27</cell><cell>0.17</cell><cell>0.26</cell><cell>0.18</cell></row></table><note></note></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_3"><head>TABLE 4</head><label>4</label><figDesc>Correlation of metabolic parameters with glucocorticoid secretion rate and 11␤-HSD1 activity (as measured by the urinary 5␣THF ϩ THF-to-THE ratio) analyzed by GC/MS</figDesc><table><row><cell></cell><cell></cell><cell cols="2">Women (n ϭ 49)</cell><cell></cell><cell></cell><cell cols="2">Men (n ϭ 30)</cell><cell></cell></row><row><cell></cell><cell cols="2">Total glucocorticoid</cell><cell>(5␣THF ϩ</cell><cell></cell><cell cols="2">Total glucocorticoid</cell><cell>(5␣THF ϩ</cell><cell></cell></row><row><cell></cell><cell cols="2">secretion rate</cell><cell cols="2">THF)-to-THF ratio</cell><cell cols="2">secretion rate</cell><cell cols="2">THF)-to-THF ratio</cell></row><row><cell></cell><cell>Correlation</cell><cell></cell><cell>Correlation</cell><cell></cell><cell>Correlation</cell><cell></cell><cell>Correlation</cell><cell></cell></row><row><cell></cell><cell>coefficient (R)</cell><cell>P</cell><cell>coefficient (R)</cell><cell>P</cell><cell>coefficient (R)</cell><cell>P</cell><cell>coefficient (R)</cell><cell>P</cell></row><row><cell>Insulin sensitivity and</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>glucose tolerance</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>Fasting glucose</cell><cell>0.06</cell><cell>0.70</cell><cell>Ϫ0.05</cell><cell>0.74</cell><cell>0.07</cell><cell>0.73</cell><cell>0.28</cell><cell>0.14</cell></row><row><cell>2-h glucose</cell><cell>0.22</cell><cell>0.15</cell><cell>Ϫ0.01</cell><cell>0.97</cell><cell>Ϫ0.10</cell><cell>0.59</cell><cell>0.34</cell><cell>0.07</cell></row><row><cell>Fasting insulin</cell><cell>0.25</cell><cell>0.09</cell><cell>Ϫ0.01</cell><cell>0.95</cell><cell>0.04</cell><cell>0.83</cell><cell>0.37</cell><cell>0.05</cell></row><row><cell>2-h insulin</cell><cell>0.34</cell><cell>0.02</cell><cell>0.07</cell><cell>0.64</cell><cell>0.12</cell><cell>0.53</cell><cell>0.03</cell><cell>0.88</cell></row><row><cell>AUC insulin</cell><cell>0.17</cell><cell>0.25</cell><cell>Ϫ0.08</cell><cell>0.61</cell><cell>0.07</cell><cell>0.70</cell><cell>0.01</cell><cell>0.96</cell></row><row><cell>A1C</cell><cell>Ϫ0.00</cell><cell>1.0</cell><cell>Ϫ0.12</cell><cell>0.47</cell><cell>Ϫ0.16</cell><cell>0.43</cell><cell>0.45</cell><cell>0.17</cell></row><row><cell>HOMA-%B</cell><cell>0.19</cell><cell>0.20</cell><cell>Ϫ0.04</cell><cell>0.78</cell><cell>0.08</cell><cell>0.67</cell><cell>0.22</cell><cell>0.26</cell></row><row><cell>HOMA-%S</cell><cell>Ϫ0.18</cell><cell>0.24</cell><cell>0.10</cell><cell>0.49</cell><cell>Ϫ0.16</cell><cell>0.42</cell><cell>Ϫ0.35</cell><cell>0.06</cell></row><row><cell>HOMA-R</cell><cell>0.25</cell><cell>0.09</cell><cell>Ϫ0.00</cell><cell>0.98</cell><cell>0.04</cell><cell>0.85</cell><cell>0.38</cell><cell>0.04</cell></row><row><cell>Anthropometry</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>BMI</cell><cell>0.32</cell><cell>0.03</cell><cell>0.13</cell><cell>0.38</cell><cell>0.21</cell><cell>0.28</cell><cell>0.14</cell><cell>0.46</cell></row><row><cell>Waist circumference</cell><cell>0.32</cell><cell>0.03</cell><cell>Ϫ0.03</cell><cell>0.87</cell><cell>0.07</cell><cell>0.73</cell><cell>0.28</cell><cell>0.14</cell></row><row><cell>WHR</cell><cell>Ϫ0.04</cell><cell>0.70</cell><cell>Ϫ0.18</cell><cell>0.23</cell><cell>Ϫ0.05</cell><cell>0.78</cell><cell>Ϫ0.02</cell><cell>0.92</cell></row><row><cell>Body composition (DEXA)</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>Trunk fat mass</cell><cell>0.44</cell><cell>0.002</cell><cell>0.05</cell><cell>0.76</cell><cell>0.22</cell><cell>0.27</cell><cell>0.35</cell><cell>0.07</cell></row><row><cell>Trunk fat-free mass</cell><cell>0.44</cell><cell>0.002</cell><cell>Ϫ0.06</cell><cell>0.68</cell><cell>0.28</cell><cell>0.15</cell><cell>0.33</cell><cell>0.09</cell></row><row><cell>Total fat mass</cell><cell>0.41</cell><cell>0.006</cell><cell>0.14</cell><cell>0.37</cell><cell>0.25</cell><cell>0.20</cell><cell>0.25</cell><cell>0.20</cell></row><row><cell>Total fat-free mass</cell><cell>0.38</cell><cell>0.01</cell><cell>Ϫ0.06</cell><cell>0.67</cell><cell>0.12</cell><cell>0.56</cell><cell>031</cell><cell>0.11</cell></row><row><cell>Total % fat</cell><cell>0.19</cell><cell>0.20</cell><cell>0.21</cell><cell>0.16</cell><cell>0.23</cell><cell>0.23</cell><cell>0.14</cell><cell>0.49</cell></row><row><cell>Trunk fat-to-limb fat ratio</cell><cell>0.19</cell><cell>0.22</cell><cell>Ϫ0.23</cell><cell>0.13</cell><cell>Ϫ0.005</cell><cell>0.98</cell><cell>0.31</cell><cell>0.11</cell></row></table><note></note></figure>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot">DIABETES, VOL. 57, OCTOBER 2008</note>
		</body>
		<back>

			<div type="acknowledgement">
<div xmlns="http://www.tei-c.org/ns/1.0"><head>ACKNOWLEDGMENTS</head><p>This study was funded by the Wellcome Trust We thank all the nursing staff on the Wellcome Trust Clinical Research facility, Queen Elizabeth Hospital, Birmingham where this study took place.</p></div>
			</div>

			<div type="references">

				<listBibl>

<biblStruct xml:id="b0">
	<analytic>
		<title level="a" type="main">Guidelines for Healthy Weight</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Walter</forename><forename type="middle">C</forename><surname>Willett</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">William</forename><forename type="middle">H</forename><surname>Dietz</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Graham</forename><forename type="middle">A</forename><surname>Colditz</surname></persName>
		</author>
		<idno type="DOI">10.1056/nejm199908053410607</idno>
		<idno type="PMID">10432328</idno>
		<ptr type="open-access" target="https://espace.library.uq.edu.au/view/UQ:144962/UQ144962_OA.pdf" />
	</analytic>
	<monogr>
		<title level="j">New England Journal of Medicine</title>
		<title level="j" type="abbrev">N Engl J Med</title>
		<idno type="ISSN">0028-4793</idno>
		<idno type="ISSNe">1533-4406</idno>
		<imprint>
			<biblScope unit="volume">341</biblScope>
			<biblScope unit="issue">6</biblScope>
			<biblScope unit="page" from="427" to="434" />
			<date type="published" when="1999-08-05" />
			<publisher>New England Journal of Medicine (NEJM/MMS)</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b1">
	<analytic>
		<title level="a" type="main">Insulin Resistance as the Underlying Cause for the Metabolic Syndrome</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Danielle</forename><surname>Lann</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Derek</forename><surname>Leroith</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.mcna.2007.06.012</idno>
		<idno type="PMID">17964909</idno>
	</analytic>
	<monogr>
		<title level="j">Medical Clinics of North America</title>
		<title level="j" type="abbrev">Medical Clinics of North America</title>
		<idno type="ISSN">0025-7125</idno>
		<imprint>
			<biblScope unit="volume">91</biblScope>
			<biblScope unit="issue">6</biblScope>
			<biblScope unit="page" from="1063" to="1077" />
			<date type="published" when="2007-11" />
			<publisher>Elsevier BV</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b2">
	<analytic>
		<title level="a" type="main">Prevalence and Predictors of Risk for Type 2 Diabetes Mellitus and Impaired Glucose Tolerance in Polycystic Ovary Syndrome: A Prospective, Controlled Study in 254 Affected Women</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">R</forename><forename type="middle">S</forename><surname>Legro</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">A</forename><forename type="middle">R</forename><surname>Kunselman</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">W</forename><forename type="middle">C</forename><surname>Dodson</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">A</forename><surname>Dunaif</surname></persName>
		</author>
		<idno type="DOI">10.1210/jc.84.1.165</idno>
		<idno type="PMID">9920077</idno>
	</analytic>
	<monogr>
		<title level="j">Journal of Clinical Endocrinology &amp; Metabolism</title>
		<title level="j" type="abbrev">Journal of Clinical Endocrinology &amp; Metabolism</title>
		<idno type="ISSN">0021-972X</idno>
		<imprint>
			<biblScope unit="volume">84</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="165" to="169" />
			<date type="published" when="1999-01-01" />
			<publisher>The Endocrine Society</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b3">
	<analytic>
		<title level="a" type="main">Weight Gain as a Risk Factor for Clinical Diabetes Mellitus in Women</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Graham</forename><forename type="middle">A</forename><surname>Colditz</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">W</forename><forename type="middle">C</forename><surname>Willett</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">A</forename><surname>Rotnitzky</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><forename type="middle">E</forename><surname>Manson</surname></persName>
		</author>
		<idno type="DOI">10.7326/0003-4819-122-7-199504010-00001</idno>
		<idno type="PMID">7872581</idno>
	</analytic>
	<monogr>
		<title level="j">Annals of Internal Medicine</title>
		<title level="j" type="abbrev">Ann Intern Med</title>
		<idno type="ISSN">0003-4819</idno>
		<imprint>
			<biblScope unit="volume">122</biblScope>
			<biblScope unit="issue">7</biblScope>
			<biblScope unit="page">481</biblScope>
			<date type="published" when="1995-04-01" />
			<publisher>American College of Physicians</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b4">
	<analytic>
		<title level="a" type="main">Obesity, Fat Distribution, and Weight Gain as Risk Factors for Clinical Diabetes in Men</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><forename type="middle">M</forename><surname>Chan</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">E</forename><forename type="middle">B</forename><surname>Rimm</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">G</forename><forename type="middle">A</forename><surname>Colditz</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><forename type="middle">J</forename><surname>Stampfer</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">W</forename><forename type="middle">C</forename><surname>Willett</surname></persName>
		</author>
		<idno type="DOI">10.2337/diacare.17.9.961</idno>
		<idno type="PMID">7988316</idno>
		<ptr type="open-access" target="http://pdfs.semanticscholar.org/2e5d/3eeb4fbcfa60203f2bba46cb0fbe3c3a2e84.pdf" />
	</analytic>
	<monogr>
		<title level="j">Diabetes Care</title>
		<title level="j" type="abbrev">Diabetes Care</title>
		<idno type="ISSN">0149-5992</idno>
		<idno type="ISSNe">1935-5548</idno>
		<imprint>
			<biblScope unit="volume">17</biblScope>
			<biblScope unit="issue">9</biblScope>
			<biblScope unit="page" from="961" to="969" />
			<date type="published" when="1994-09-01" />
			<publisher>American Diabetes Association</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b5">
	<analytic>
		<title level="a" type="main">Annual incidence and relative risk of diabetes in people with various categories of dysglycemia: A systematic overview and meta-analysis of prospective studies</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Hertzel</forename><forename type="middle">C</forename><surname>Gerstein</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Pasqualina</forename><surname>Santaguida</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Parminder</forename><surname>Raina</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Katherine</forename><forename type="middle">M</forename><surname>Morrison</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Cynthia</forename><surname>Balion</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Dereck</forename><surname>Hunt</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Hossein</forename><surname>Yazdi</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Lynda</forename><surname>Booker</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.diabres.2007.05.004</idno>
		<idno type="PMID">17601626</idno>
	</analytic>
	<monogr>
		<title level="j">Diabetes Research and Clinical Practice</title>
		<title level="j" type="abbrev">Diabetes Research and Clinical Practice</title>
		<idno type="ISSN">0168-8227</idno>
		<imprint>
			<biblScope unit="volume">78</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="305" to="312" />
			<date type="published" when="2007-12" />
			<publisher>Elsevier BV</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b6">
	<analytic>
		<title level="a" type="main">Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">W</forename><forename type="middle">C</forename><surname>Knowler</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">E</forename><surname>Barrett-Connor</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><forename type="middle">E</forename><surname>Fowler</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">R</forename><forename type="middle">F</forename><surname>Hamman</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><forename type="middle">M</forename><surname>Lachin</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">E</forename><forename type="middle">A</forename><surname>Walker</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">D</forename><forename type="middle">M</forename><surname>Nathan</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">N Engl J Med</title>
		<imprint>
			<biblScope unit="volume">346</biblScope>
			<biblScope unit="page" from="393" to="403" />
			<date type="published" when="2002" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b7">
	<analytic>
		<title level="a" type="main">Prevention of Type 2 Diabetes Mellitus by Changes in Lifestyle among Subjects with Impaired Glucose Tolerance</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Jaakko</forename><surname>Tuomilehto</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Jaana</forename><surname>Lindström</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Johan</forename><forename type="middle">G</forename><surname>Eriksson</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Timo</forename><forename type="middle">T</forename><surname>Valle</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Helena</forename><surname>Hämäläinen</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Pirjo</forename><surname>Ilanne-Parikka</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Sirkka</forename><surname>Keinänen-Kiukaanniemi</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Mauri</forename><surname>Laakso</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Anne</forename><surname>Louheranta</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Merja</forename><surname>Rastas</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Virpi</forename><surname>Salminen</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Sirkka</forename><surname>Aunola</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Zygimantas</forename><surname>Cepaitis</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Vladislav</forename><surname>Moltchanov</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Martti</forename><surname>Hakumäki</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Marjo</forename><surname>Mannelin</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Vesa</forename><surname>Martikkala</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Jouko</forename><surname>Sundvall</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Matti</forename><surname>Uusitupa</surname></persName>
		</author>
		<idno type="DOI">10.1056/nejm200105033441801</idno>
		<idno type="PMID">11333990</idno>
	</analytic>
	<monogr>
		<title level="j">New England Journal of Medicine</title>
		<title level="j" type="abbrev">N Engl J Med</title>
		<idno type="ISSN">0028-4793</idno>
		<idno type="ISSNe">1533-4406</idno>
		<imprint>
			<biblScope unit="volume">344</biblScope>
			<biblScope unit="issue">18</biblScope>
			<biblScope unit="page" from="1343" to="1350" />
			<date type="published" when="2001-05-03" />
			<publisher>New England Journal of Medicine (NEJM/MMS)</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b8">
	<analytic>
		<title level="a" type="main">Cortisol Effects on Body Mass, Blood Pressure, and Cholesterol in the General Population</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">R</forename><surname>Fraser</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><forename type="middle">C</forename><surname>Ingram</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">N</forename><forename type="middle">H</forename><surname>Anderson</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">C</forename><surname>Morrison</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">E</forename><surname>Davies</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><forename type="middle">M C</forename><surname>Connell</surname></persName>
		</author>
		<idno type="DOI">10.1161/01.hyp.33.6.1364</idno>
		<idno type="PMID">10373217</idno>
		<ptr type="open-access" target="https://www.ahajournals.org/doi/pdf/10.1161/01.HYP.33.6.1364" />
	</analytic>
	<monogr>
		<title level="j">Hypertension</title>
		<title level="j" type="abbrev">Hypertension</title>
		<idno type="ISSN">0194-911X</idno>
		<idno type="ISSNe">1524-4563</idno>
		<imprint>
			<biblScope unit="volume">33</biblScope>
			<biblScope unit="issue">6</biblScope>
			<biblScope unit="page" from="1364" to="1368" />
			<date type="published" when="1999-06-01" />
			<publisher>Ovid Technologies (Wolters Kluwer Health)</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b9">
	<analytic>
		<title level="a" type="main">11β-Hydroxysteroid Dehydrogenase Type 1: A Tissue-Specific Regulator of Glucocorticoid Response</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Jeremy</forename><forename type="middle">W</forename><surname>Tomlinson</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Elizabeth</forename><forename type="middle">A</forename><surname>Walker</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Iwona</forename><forename type="middle">J</forename><surname>Bujalska</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Nicole</forename><surname>Draper</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Gareth</forename><forename type="middle">G</forename><surname>Lavery</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Mark</forename><forename type="middle">S</forename><surname>Cooper</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Martin</forename><surname>Hewison</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Paul</forename><forename type="middle">M</forename><surname>Stewart</surname></persName>
		</author>
		<idno type="DOI">10.1210/er.2003-0031</idno>
		<idno type="PMID">15466942</idno>
		<ptr type="open-access" target="https://academic.oup.com/edrv/article-pdf/25/5/831/8862391/edrv0831.pdf" />
	</analytic>
	<monogr>
		<title level="j">Endocrine Reviews</title>
		<title level="j" type="abbrev">Endocrine Reviews</title>
		<idno type="ISSN">0163-769X</idno>
		<idno type="ISSNe">1945-7189</idno>
		<imprint>
			<biblScope unit="volume">25</biblScope>
			<biblScope unit="issue">5</biblScope>
			<biblScope unit="page" from="831" to="866" />
			<date type="published" when="2004-10" />
			<publisher>The Endocrine Society</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b10">
	<analytic>
		<title level="a" type="main">Hexose-6-phosphate Dehydrogenase Knock-out Mice Lack 11β-Hydroxysteroid Dehydrogenase Type 1-mediated Glucocorticoid Generation</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Gareth</forename><forename type="middle">G</forename><surname>Lavery</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Elizabeth</forename><forename type="middle">A</forename><surname>Walker</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Nicole</forename><surname>Draper</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Pancharatnam</forename><surname>Jeyasuria</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Josep</forename><surname>Marcos</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Cedric</forename><forename type="middle">H L</forename><surname>Shackleton</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Keith</forename><forename type="middle">L</forename><surname>Parker</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Perrin</forename><forename type="middle">C</forename><surname>White</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Paul</forename><forename type="middle">M</forename><surname>Stewart</surname></persName>
		</author>
		<idno type="DOI">10.1074/jbc.m512635200</idno>
		<idno type="PMID">16356929</idno>
		<ptr type="open-access" target="http://www.jbc.org/content/281/10/6546.full.pdf" />
	</analytic>
	<monogr>
		<title level="j">Journal of Biological Chemistry</title>
		<title level="j" type="abbrev">J. Biol. Chem.</title>
		<idno type="ISSN">0021-9258</idno>
		<idno type="ISSNe">1083-351X</idno>
		<imprint>
			<biblScope unit="volume">281</biblScope>
			<biblScope unit="issue">10</biblScope>
			<biblScope unit="page" from="6546" to="6551" />
			<date type="published" when="2005-12-15" />
			<publisher>American Society for Biochemistry &amp; Molecular Biology (ASBMB)</publisher>
		</imprint>
	</monogr>
	<note>Epub ahead of print</note>
</biblStruct>

<biblStruct xml:id="b11">
	<analytic>
		<title level="a" type="main">Hexose-6-phosphate dehydrogenase confers oxo-reductase activity upon 11β-hydroxysteroid dehydrogenase type 1</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Iwona</forename><forename type="middle">J</forename><surname>Bujalska</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Nicole</forename><surname>Draper</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Zoi</forename><surname>Michailidou</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Jeremy</forename><forename type="middle">W</forename><surname>Tomlinson</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Perrin</forename><forename type="middle">C</forename><surname>White</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Karen</forename><forename type="middle">E</forename><surname>Chapman</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Elizabeth</forename><forename type="middle">A</forename><surname>Walker</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Paul</forename><forename type="middle">M</forename><surname>Stewart</surname></persName>
		</author>
		<idno type="DOI">10.1677/jme.1.01718</idno>
		<idno type="PMID">15956339</idno>
		<ptr type="open-access" target="https://jme.bioscientifica.com/downloadpdf/journals/jme/34/3/0340675.pdf" />
	</analytic>
	<monogr>
		<title level="j">Journal of Molecular Endocrinology</title>
		<idno type="ISSN">0952-5041</idno>
		<idno type="ISSNe">1479-6813</idno>
		<imprint>
			<biblScope unit="volume">34</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="675" to="684" />
			<date type="published" when="2005-06" />
			<publisher>Bioscientifica</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b12">
	<analytic>
		<title level="a" type="main">Selective inhibition of 11beta-hydroxysteroid dehydrogenase type 1 decreases blood glucose concentrations in hyperglycaemic mice</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">P</forename><surname>Alberts</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">L</forename><surname>Engblom</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">N</forename><surname>Edling</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><surname>Forsgren</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">G</forename><surname>Klingstrom</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">C</forename><surname>Larsson</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Y</forename><surname>Ronquist-Nii</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">B</forename><surname>Ohman</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">L</forename><surname>Abrahmsen</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Diabetologia</title>
		<imprint>
			<biblScope unit="volume">45</biblScope>
			<biblScope unit="page" from="1528" to="1532" />
			<date type="published" when="2002" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b13">
	<analytic>
		<title level="a" type="main">Selective Inhibition of 11β-Hydroxysteroid Dehydrogenase Type 1 Improves Hepatic Insulin Sensitivity in Hyperglycemic Mice Strains</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Pēteris</forename><surname>Alberts</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Cecilia</forename><surname>Nilsson</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Göran</forename><surname>Selén</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Lars</forename><forename type="middle">O M</forename><surname>Engblom</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Naimie</forename><forename type="middle">H M</forename><surname>Edling</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Solveig</forename><surname>Norling</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Gunnel</forename><surname>Klingström</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Catarina</forename><surname>Larsson</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Margareta</forename><surname>Forsgren</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Mandana</forename><surname>Ashkzari</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Catrine</forename><forename type="middle">E</forename><surname>Nilsson</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Maj</forename><surname>Fiedler</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Elisabet</forename><surname>Bergqvist</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Birgitta</forename><surname>Öhman</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Eva</forename><surname>Björkstrand</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Lars</forename><forename type="middle">B</forename><surname>Abrahmsén</surname></persName>
		</author>
		<idno type="DOI">10.1210/en.2003-0344</idno>
		<idno type="PMID">12960099</idno>
		<ptr type="open-access" target="https://academic.oup.com/endo/article-pdf/144/11/4755/10785338/endo4755.pdf" />
	</analytic>
	<monogr>
		<title level="j">Endocrinology</title>
		<title level="j" type="abbrev">Endocrinology</title>
		<idno type="ISSN">0013-7227</idno>
		<idno type="ISSNe">1945-7170</idno>
		<imprint>
			<biblScope unit="volume">144</biblScope>
			<biblScope unit="issue">11</biblScope>
			<biblScope unit="page" from="4755" to="4762" />
			<date type="published" when="2003-11" />
			<publisher>The Endocrine Society</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b14">
	<analytic>
		<title level="a" type="main">Depot-Specific Modulation of Rat Intraabdominal Adipose Tissue Lipid Metabolism by Pharmacological Inhibition of 11β-Hydroxysteroid Dehydrogenase Type 1</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Magalie</forename><surname>Berthiaume</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Mathieu</forename><surname>Laplante</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">William</forename><surname>Festuccia</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Yves</forename><surname>Gélinas</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Sébastien</forename><surname>Poulin</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Josée</forename><surname>Lalonde</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Denis</forename><forename type="middle">R</forename><surname>Joanisse</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Rolf</forename><surname>Thieringer</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Yves</forename><surname>Deshaies</surname></persName>
		</author>
		<idno type="DOI">10.1210/en.2006-1199</idno>
		<idno type="PMID">17272400</idno>
		<ptr type="open-access" target="https://academic.oup.com/endo/article-pdf/148/5/2391/11060529/endo2391.pdf" />
	</analytic>
	<monogr>
		<title level="j">Endocrinology</title>
		<title level="j" type="abbrev">Endocrinology</title>
		<idno type="ISSN">0013-7227</idno>
		<idno type="ISSNe">1945-7170</idno>
		<imprint>
			<biblScope unit="volume">148</biblScope>
			<biblScope unit="issue">5</biblScope>
			<biblScope unit="page" from="2391" to="2397" />
			<date type="published" when="2007-05" />
			<publisher>The Endocrine Society</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b15">
	<analytic>
		<title level="a" type="main">Demonstration of Proof of Mechanism and Pharmacokinetics and Pharmacodynamic Relationship with 4&apos;-Cyano-biphenyl-4-sulfonic Acid (6-Amino-pyridin-2-yl)-amide (PF-915275), an Inhibitor of 11 -Hydroxysteroid Dehydrogenase Type 1, in Cynomolgus Monkeys</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">B</forename><forename type="middle">G</forename><surname>Bhat</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">N</forename><surname>Hosea</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">A</forename><surname>Fanjul</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><surname>Herrera</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><surname>Chapman</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">F</forename><surname>Thalacker</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">P</forename><forename type="middle">M</forename><surname>Stewart</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">P</forename><forename type="middle">A</forename><surname>Rejto</surname></persName>
		</author>
		<idno type="DOI">10.1124/jpet.107.128280</idno>
		<idno type="PMID">17921190</idno>
	</analytic>
	<monogr>
		<title level="j">Journal of Pharmacology and Experimental Therapeutics</title>
		<title level="j" type="abbrev">Journal of Pharmacology and Experimental Therapeutics</title>
		<idno type="ISSN">0022-3565</idno>
		<idno type="ISSNe">1521-0103</idno>
		<imprint>
			<biblScope unit="volume">324</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="299" to="305" />
			<date type="published" when="2007-10-05" />
			<publisher>American Society for Pharmacology &amp; Experimental Therapeutics (ASPET)</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b16">
	<analytic>
		<title level="a" type="main">Steroid 5-alpha Reductase: Two Genes/Two Enzymes</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">D</forename><forename type="middle">W</forename><surname>Russell</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><forename type="middle">D</forename><surname>Wilson</surname></persName>
		</author>
		<idno type="DOI">10.1146/annurev.biochem.63.1.25</idno>
	</analytic>
	<monogr>
		<title level="j">Annual Review of Biochemistry</title>
		<idno type="ISSN">0066-4154</idno>
		<imprint>
			<biblScope unit="volume">63</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="25" to="61" />
			<date type="published" when="1994-01-01" />
			<publisher>Annual Reviews</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b17">
	<analytic>
		<title level="a" type="main">Intra-adipose sex steroid metabolism and body fat distribution in idiopathic human obesity</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Deborah</forename><forename type="middle">J</forename><surname>Wake</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Magnus</forename><surname>Strand</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Eva</forename><surname>Rask</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Jukka</forename><surname>Westerbacka</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Dawn</forename><forename type="middle">E W</forename><surname>Livingstone</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Stefan</forename><surname>Soderberg</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Ruth</forename><surname>Andrew</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Hannele</forename><surname>Yki-Jarvinen</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Tommy</forename><surname>Olsson</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Brian</forename><forename type="middle">R</forename><surname>Walker</surname></persName>
		</author>
		<idno type="DOI">10.1111/j.1365-2265.2007.02755.x</idno>
		<idno type="PMID">17302881</idno>
		<idno type="ark">ark:/67375/WNG-DW77G9NB-3</idno>
		<idno type="istexId">003591B6EDC5C18720AF68AACE400A4D2FA97E9B</idno>
	</analytic>
	<monogr>
		<title level="j">Clinical Endocrinology</title>
		<title level="j" type="abbrev">Clin Endocrinol</title>
		<idno type="ISSN">0300-0664</idno>
		<idno type="ISSNe">1365-2265</idno>
		<imprint>
			<biblScope unit="volume">66</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="440" to="446" />
			<date type="published" when="2007-03" />
			<publisher>Wiley</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b18">
	<analytic>
		<title level="a" type="main">Urinary free cortisone and the assessment of 11beta-hydroxysteroid dehydrogenase activity in man</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Mario</forename><surname>Palermo</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Cedric</forename><forename type="middle">H L</forename><surname>Shackleton</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Franco</forename><surname>Mantero</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Paul</forename><forename type="middle">M</forename><surname>Stewart</surname></persName>
		</author>
		<idno type="DOI">10.1046/j.1365-2265.1996.00853.x</idno>
		<idno type="PMID">8977758</idno>
		<idno type="ark">ark:/67375/WNG-BJ90HZCX-M</idno>
		<idno type="istexId">F5FF230B8075968864000ABFF1DB5FE826DDDDA9</idno>
	</analytic>
	<monogr>
		<title level="j">Clinical Endocrinology</title>
		<title level="j" type="abbrev">Clin Endocrinol</title>
		<idno type="ISSN">0300-0664</idno>
		<idno type="ISSNe">1365-2265</idno>
		<imprint>
			<biblScope unit="volume">45</biblScope>
			<biblScope unit="issue">5</biblScope>
			<biblScope unit="page" from="605" to="611" />
			<date type="published" when="1996-11" />
			<publisher>Wiley</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b19">
	<analytic>
		<title level="a" type="main">Weight Loss Increases 11β-Hydroxysteroid Dehydrogenase Type 1 Expression in Human Adipose Tissue</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Jeremy</forename><forename type="middle">W</forename><surname>Tomlinson</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Jasbir</forename><forename type="middle">S</forename><surname>Moore</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Penny</forename><forename type="middle">M S</forename><surname>Clark</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Geoff</forename><surname>Holder</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Lynette</forename><surname>Shakespeare</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Paul</forename><forename type="middle">M</forename><surname>Stewart</surname></persName>
		</author>
		<idno type="DOI">10.1210/jc.2003-031376</idno>
		<idno type="PMID">15181046</idno>
		<ptr type="open-access" target="https://academic.oup.com/jcem/article-pdf/89/6/2711/10743402/jcem2711.pdf" />
	</analytic>
	<monogr>
		<title level="j">The Journal of Clinical Endocrinology &amp; Metabolism</title>
		<title level="j" type="abbrev">The Journal of Clinical Endocrinology &amp; Metabolism</title>
		<idno type="ISSN">0021-972X</idno>
		<idno type="ISSNe">1945-7197</idno>
		<imprint>
			<biblScope unit="volume">89</biblScope>
			<biblScope unit="issue">6</biblScope>
			<biblScope unit="page" from="2711" to="2716" />
			<date type="published" when="2004-06" />
			<publisher>The Endocrine Society</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b20">
	<analytic>
		<title level="a" type="main">Cortisol Metabolism in Human Obesity: Impaired Cortisone-&gt;Cortisol Conversion in Subjects with Central Adiposity</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">P</forename><forename type="middle">M</forename><surname>Stewart</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">A</forename><surname>Boulton</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><surname>Kumar</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">P</forename><forename type="middle">M</forename><surname>Clark</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">C</forename><forename type="middle">H</forename><surname>Shackleton</surname></persName>
		</author>
		<idno type="DOI">10.1210/jc.84.3.1022</idno>
		<idno type="PMID">10084590</idno>
	</analytic>
	<monogr>
		<title level="j">Journal of Clinical Endocrinology &amp; Metabolism</title>
		<title level="j" type="abbrev">Journal of Clinical Endocrinology &amp; Metabolism</title>
		<idno type="ISSN">0021-972X</idno>
		<imprint>
			<biblScope unit="volume">84</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="1022" to="1027" />
			<date type="published" when="1999-03-01" />
			<publisher>The Endocrine Society</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b21">
	<analytic>
		<title level="a" type="main">Use and Abuse of HOMA Modeling</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">T</forename><forename type="middle">M</forename><surname>Wallace</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><forename type="middle">C</forename><surname>Levy</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">D</forename><forename type="middle">R</forename><surname>Matthews</surname></persName>
		</author>
		<idno type="DOI">10.2337/diacare.27.6.1487</idno>
		<idno type="PMID">15161807</idno>
		<ptr type="open-access" target="http://care.diabetesjournals.org/content/27/6/1487.full.pdf" />
	</analytic>
	<monogr>
		<title level="j">Diabetes Care</title>
		<title level="j" type="abbrev">Diabetes Care</title>
		<idno type="ISSN">0149-5992</idno>
		<idno type="ISSNe">1935-5548</idno>
		<imprint>
			<biblScope unit="volume">27</biblScope>
			<biblScope unit="issue">6</biblScope>
			<biblScope unit="page" from="1487" to="1495" />
			<date type="published" when="2004-05-25" />
			<publisher>American Diabetes Association</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b22">
	<analytic>
		<title level="a" type="main">11β-Hydroxysteroid Dehydrogenase Type 1 Regulation by Intracellular Glucose 6-Phosphate Provides Evidence for a Novel Link between Glucose Metabolism and Hypothalamo-Pituitary-Adrenal Axis Function</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Elizabeth</forename><forename type="middle">A</forename><surname>Walker</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Adeeba</forename><surname>Ahmed</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Gareth</forename><forename type="middle">G</forename><surname>Lavery</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Jeremy</forename><forename type="middle">W</forename><surname>Tomlinson</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">So</forename><forename type="middle">Youn</forename><surname>Kim</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Mark</forename><forename type="middle">S</forename><surname>Cooper</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Jonathan</forename><forename type="middle">P</forename><surname>Ride</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Beverly</forename><forename type="middle">A</forename><surname>Hughes</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Cedric</forename><forename type="middle">H L</forename><surname>Shackleton</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Patrick</forename><surname>Mckiernan</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Elwyn</forename><surname>Elias</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Janice</forename><forename type="middle">Y</forename><surname>Chou</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Paul</forename><forename type="middle">M</forename><surname>Stewart</surname></persName>
		</author>
		<idno type="DOI">10.1074/jbc.m704144200</idno>
		<idno type="PMID">17588937</idno>
		<ptr type="open-access" target="http://www.jbc.org/content/282/37/27030.full.pdf" />
	</analytic>
	<monogr>
		<title level="j">Journal of Biological Chemistry</title>
		<title level="j" type="abbrev">J. Biol. Chem.</title>
		<idno type="ISSN">0021-9258</idno>
		<idno type="ISSNe">1083-351X</idno>
		<imprint>
			<biblScope unit="volume">282</biblScope>
			<biblScope unit="issue">37</biblScope>
			<biblScope unit="page" from="27030" to="27036" />
			<date type="published" when="2007-06-22" />
			<publisher>American Society for Biochemistry &amp; Molecular Biology (ASBMB)</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b23">
	<analytic>
		<title level="a" type="main">Expression of 11β-Hydroxysteroid Dehydrogenase Type 1 in Adipose Tissue Is Not Increased in Human Obesity</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><forename type="middle">W</forename><surname>Tomlinson</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">B</forename><surname>Sinha</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">I</forename><surname>Bujalska</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><surname>Hewison</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">P</forename><forename type="middle">M</forename><surname>Stewart</surname></persName>
		</author>
		<idno type="DOI">10.1210/jc.2002-020687</idno>
		<idno type="PMID">12466364</idno>
		<ptr type="open-access" target="https://academic.oup.com/jcem/article-pdf/87/12/5630/9043159/jcem5630.pdf" />
	</analytic>
	<monogr>
		<title level="j">The Journal of Clinical Endocrinology &amp; Metabolism</title>
		<title level="j" type="abbrev">The Journal of Clinical Endocrinology &amp; Metabolism</title>
		<idno type="ISSN">0021-972X</idno>
		<idno type="ISSNe">1945-7197</idno>
		<imprint>
			<biblScope unit="volume">87</biblScope>
			<biblScope unit="issue">12</biblScope>
			<biblScope unit="page" from="5630" to="5635" />
			<date type="published" when="2002-12" />
			<publisher>The Endocrine Society</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b24">
	<analytic>
		<title level="a" type="main">Tissue-Specific Dysregulation of Cortisol Metabolism in Human Obesity</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">E</forename><surname>Rask</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">T</forename><surname>Olsson</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><surname>Soderberg</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">R</forename><surname>Andrew</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">D</forename><forename type="middle">E</forename><surname>Livingstone</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Johnson</forename><forename type="middle">O</forename><surname>Walker</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">B</forename><forename type="middle">R</forename></persName>
		</author>
		<idno type="DOI">10.1210/jc.86.3.1418</idno>
		<idno type="PMID">11238541</idno>
		<ptr type="open-access" target="https://academic.oup.com/jcem/article-pdf/86/3/1418/9162568/jcem1418.pdf" />
	</analytic>
	<monogr>
		<title level="j">Journal of Clinical Endocrinology &amp; Metabolism</title>
		<title level="j" type="abbrev">Journal of Clinical Endocrinology &amp; Metabolism</title>
		<idno type="ISSN">0021-972X</idno>
		<imprint>
			<biblScope unit="volume">86</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="1418" to="1421" />
			<date type="published" when="2001-03-01" />
			<publisher>The Endocrine Society</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b25">
	<analytic>
		<title level="a" type="main">Tissue-Specific Changes in Peripheral Cortisol Metabolism in Obese Women: Increased Adipose 11β-Hydroxysteroid Dehydrogenase Type 1 Activity</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Eva</forename><surname>Rask</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Brian</forename><forename type="middle">R</forename><surname>Walker</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Stefan</forename><surname>Söderberg</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Dawn</forename><forename type="middle">E W</forename><surname>Livingstone</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Mats</forename><surname>Eliasson</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Owe</forename><surname>Johnson</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Ruth</forename><surname>Andrew</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Tommy</forename><surname>Olsson</surname></persName>
		</author>
		<idno type="DOI">10.1210/jcem.87.7.8661</idno>
		<idno type="PMID">12107245</idno>
		<ptr type="open-access" target="https://academic.oup.com/jcem/article-pdf/87/7/3330/9158605/jcem3330.pdf" />
	</analytic>
	<monogr>
		<title level="j">The Journal of Clinical Endocrinology &amp; Metabolism</title>
		<title level="j" type="abbrev">The Journal of Clinical Endocrinology &amp; Metabolism</title>
		<idno type="ISSN">0021-972X</idno>
		<idno type="ISSNe">1945-7197</idno>
		<imprint>
			<biblScope unit="volume">87</biblScope>
			<biblScope unit="issue">7</biblScope>
			<biblScope unit="page" from="3330" to="3336" />
			<date type="published" when="2002-07" />
			<publisher>The Endocrine Society</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b26">
	<analytic>
		<title level="a" type="main">Expression of the mRNA Coding for 11 -Hydroxysteroid Dehydrogenase Type 1 in Adipose Tissue from Obese Patients: An in Situ Hybridization Study</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">O</forename><surname>Paulmyer-Lacroix</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><surname>Boullu</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">C</forename><surname>Oliver</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><forename type="middle">C</forename><surname>Alessi</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><surname>Grino</surname></persName>
		</author>
		<idno type="DOI">10.1210/jc.87.6.2701</idno>
		<idno type="PMID">12050237</idno>
	</analytic>
	<monogr>
		<title level="j">Journal of Clinical Endocrinology &amp; Metabolism</title>
		<title level="j" type="abbrev">Journal of Clinical Endocrinology &amp; Metabolism</title>
		<idno type="ISSN">0021-972X</idno>
		<imprint>
			<biblScope unit="volume">87</biblScope>
			<biblScope unit="issue">6</biblScope>
			<biblScope unit="page" from="2701" to="2705" />
			<date type="published" when="2002-06-01" />
			<publisher>The Endocrine Society</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b27">
	<analytic>
		<title level="a" type="main">Subcutaneous Adipose 11β-Hydroxysteroid Dehydrogenase Type 1 Activity and Messenger Ribonucleic Acid Levels Are Associated with Adiposity and Insulinemia in Pima Indians and Caucasians</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Robert</forename><forename type="middle">S</forename><surname>Lindsay</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Deborah</forename><forename type="middle">J</forename><surname>Wake</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Saraswathy</forename><surname>Nair</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Joy</forename><surname>Bunt</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Dawn</forename><forename type="middle">E W</forename><surname>Livingstone</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Paska</forename><forename type="middle">A</forename><surname>Permana</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">P</forename><forename type="middle">Antonio</forename><surname>Tataranni</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Brian</forename><forename type="middle">R</forename><surname>Walker</surname></persName>
		</author>
		<idno type="DOI">10.1210/jc.2002-030017</idno>
		<idno type="PMID">12788882</idno>
		<ptr type="open-access" target="https://academic.oup.com/jcem/article-pdf/88/6/2738/9150722/jcem2738.pdf" />
	</analytic>
	<monogr>
		<title level="j">The Journal of Clinical Endocrinology &amp; Metabolism</title>
		<title level="j" type="abbrev">The Journal of Clinical Endocrinology &amp; Metabolism</title>
		<idno type="ISSN">0021-972X</idno>
		<idno type="ISSNe">1945-7197</idno>
		<imprint>
			<biblScope unit="volume">88</biblScope>
			<biblScope unit="issue">6</biblScope>
			<biblScope unit="page" from="2738" to="2744" />
			<date type="published" when="2003-06" />
			<publisher>The Endocrine Society</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b28">
	<analytic>
		<title level="a" type="main">Hormonal regulation of hormone-sensitive lipase activity and mRNA levels in isolated rat adipocytes</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">B</forename><forename type="middle">G</forename><surname>Slavin</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><forename type="middle">M</forename><surname>Ong</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">P</forename><forename type="middle">A</forename><surname>Kern</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Lipid Res</title>
		<imprint>
			<biblScope unit="volume">35</biblScope>
			<biblScope unit="page" from="1535" to="1541" />
			<date type="published" when="1994" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b29">
	<analytic>
		<title level="a" type="main">Inhibition of 11β-Hydroxysteroid Dehydrogenase Type 1 Activityin VivoLimits Glucocorticoid Exposure to Human Adipose Tissue and Decreases Lipolysis</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Jeremy</forename><forename type="middle">W</forename><surname>Tomlinson</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Mark</forename><surname>Sherlock</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Beverley</forename><surname>Hughes</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Susan</forename><forename type="middle">V</forename><surname>Hughes</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Fiona</forename><surname>Kilvington</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">William</forename><surname>Bartlett</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Rachel</forename><surname>Courtney</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Paul</forename><surname>Rejto</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">William</forename><surname>Carley</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Paul</forename><forename type="middle">M</forename><surname>Stewart</surname></persName>
		</author>
		<idno type="DOI">10.1210/jc.2006-2325</idno>
		<idno type="PMID">17200165</idno>
		<ptr type="open-access" target="https://academic.oup.com/jcem/article-pdf/92/3/857/9052351/jcem0857.pdf" />
	</analytic>
	<monogr>
		<title level="j">The Journal of Clinical Endocrinology &amp; Metabolism</title>
		<title level="j" type="abbrev">The Journal of Clinical Endocrinology &amp; Metabolism</title>
		<idno type="ISSN">0021-972X</idno>
		<idno type="ISSNe">1945-7197</idno>
		<imprint>
			<biblScope unit="volume">92</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="857" to="864" />
			<date type="published" when="2007-03" />
			<publisher>The Endocrine Society</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b30">
	<analytic>
		<title level="a" type="main">In Normal Men, Free Fatty Acids Reduce Peripheral but Not Splanchnic Glucose Uptake</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">V</forename><surname>Rigalleau</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">C</forename><surname>Binnert</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">K</forename><surname>Minehira</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">N</forename><surname>Stefanoni</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">P</forename><surname>Schneiter</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">E</forename><surname>Henchoz</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">O</forename><surname>Matzinger</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">C</forename><surname>Cayeux</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">E</forename><surname>Jequier</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">L</forename><surname>Tappy</surname></persName>
		</author>
		<idno type="DOI">10.2337/diabetes.50.4.727</idno>
		<idno type="PMID">11289035</idno>
	</analytic>
	<monogr>
		<title level="j">Diabetes</title>
		<title level="j" type="abbrev">Diabetes</title>
		<idno type="ISSN">0012-1797</idno>
		<idno type="ISSNe">1939-327X</idno>
		<imprint>
			<biblScope unit="volume">50</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="727" to="732" />
			<date type="published" when="2001-04-01" />
			<publisher>American Diabetes Association</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b31">
	<analytic>
		<title level="a" type="main">Sexual dimorphism of cortisol metabolism is maintained in elderly subjects and is not oestrogen dependent</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><surname>Toogood</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><surname>Taylor</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><surname>Shalet</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><surname>Monson</surname></persName>
		</author>
		<idno type="DOI">10.1046/j.1365-2265.2000.00874.x</idno>
		<idno type="PMID">10651754</idno>
		<idno type="ark">ark:/67375/WNG-V2TCX9ZR-N</idno>
		<idno type="istexId">CCA8541ABDBB1AE85163C75054CFEEB166730071</idno>
	</analytic>
	<monogr>
		<title level="j">Clinical Endocrinology</title>
		<title level="j" type="abbrev">Clin Endocrinol</title>
		<idno type="ISSN">0300-0664</idno>
		<idno type="ISSNe">1365-2265</idno>
		<imprint>
			<biblScope unit="volume">52</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="61" to="66" />
			<date type="published" when="2000-01" />
			<publisher>Wiley</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b32">
	<analytic>
		<title level="a" type="main">Cortisol Metabolism in Healthy Young Adults: Sexual Dimorphism in Activities of A-Ring Reductases, but not 11 -Hydroxysteroid Dehydrogenases</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><forename type="middle">J</forename><surname>Finken</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">R</forename><forename type="middle">C</forename><surname>Andrews</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">R</forename><surname>Andrew</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">B</forename><forename type="middle">R</forename><surname>Walker</surname></persName>
		</author>
		<idno type="DOI">10.1210/jc.84.9.3316</idno>
		<idno type="PMID">10487705</idno>
	</analytic>
	<monogr>
		<title level="j">Journal of Clinical Endocrinology &amp; Metabolism</title>
		<title level="j" type="abbrev">Journal of Clinical Endocrinology &amp; Metabolism</title>
		<idno type="ISSN">0021-972X</idno>
		<imprint>
			<biblScope unit="volume">84</biblScope>
			<biblScope unit="issue">9</biblScope>
			<biblScope unit="page" from="3316" to="3321" />
			<date type="published" when="1999-09-01" />
			<publisher>The Endocrine Society</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b33">
	<analytic>
		<title level="a" type="main">Differential regulation of the oxidative 11Î²-hydroxysteroid dehydrogenase activity in testis and liverâ</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">K</forename><forename type="middle">H</forename><surname>Nwe</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">A</forename><surname>Hamid</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">P</forename><forename type="middle">B</forename><surname>Morat</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">B</forename><forename type="middle">A</forename><surname>Khalid</surname></persName>
		</author>
		<idno type="DOI">10.1016/s0039-128x(99)00078-1</idno>
		<idno type="PMID">10624835</idno>
		<idno type="PII">S0039-128X(99)00078-1</idno>
		<idno type="ark">ark:/67375/6H6-TQFLSQ4C-C</idno>
		<idno type="istexId">1F7D75E22FABC0848864DAC0338289954BD4647F</idno>
	</analytic>
	<monogr>
		<title level="j">Steroids</title>
		<idno type="ISSN">0039-128X</idno>
		<imprint>
			<biblScope unit="volume">65</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="40" to="45" />
			<date type="published" when="2000-01" />
			<publisher>Elsevier BV</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b34">
	<analytic>
		<title level="a" type="main">Regulation of 11beta-hydroxysteroid dehydrogenase isoforms and glucocorticoid receptor gene expression in the rat uterus</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">C</forename><forename type="middle">K</forename><surname>Ho</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><surname>Tetsuka</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><forename type="middle">G</forename><surname>Hillier</surname></persName>
		</author>
		<idno type="DOI">10.1677/joe.0.1630425</idno>
		<idno type="PMID">10588816</idno>
		<ptr type="open-access" target="https://joe.bioscientifica.com/downloadpdf/journals/joe/163/3/425.pdf" />
	</analytic>
	<monogr>
		<title level="j">Journal of Endocrinology</title>
		<title level="j" type="abbrev">Journal of Endocrinology</title>
		<idno type="ISSN">0022-0795</idno>
		<idno type="ISSNe">1479-6805</idno>
		<imprint>
			<biblScope unit="volume">163</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="425" to="431" />
			<date type="published" when="1999-12-01" />
			<publisher>Bioscientifica</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b35">
	<analytic>
		<title level="a" type="main">Human endometrial decidual cell-associated 11 beta-hydroxysteroid dehydrogenase expression: its potential role in implantation</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">F</forename><surname>Arcuri</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><surname>Battistini</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">V</forename><surname>Hausknecht</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><surname>Cintorino</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">C</forename><forename type="middle">J</forename><surname>Lockwood</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">F</forename><surname>Schatz</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Early Pregnancy</title>
		<imprint>
			<biblScope unit="volume">3</biblScope>
			<biblScope unit="page" from="259" to="264" />
			<date type="published" when="1997" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b36">
	<analytic>
		<title level="a" type="main">Regulation of 11β-hydroxysteroid dehydrogenase enzymes in the rat kidney by estradiol</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Elise</forename><forename type="middle">P</forename><surname>Gomez-Sanchez</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Venkataseshu</forename><surname>Ganjam</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Yuan</forename><forename type="middle">Jian</forename><surname>Chen</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Ying</forename><surname>Liu</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Ming</forename><forename type="middle">Yi</forename><surname>Zhou</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Cigdem</forename><surname>Toroslu</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Damian</forename><forename type="middle">G</forename><surname>Romero</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Michael</forename><forename type="middle">D</forename><surname>Hughson</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Angela</forename><surname>De Rodriguez</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Celso</forename><forename type="middle">E</forename><surname>Gomez-Sanchez</surname></persName>
		</author>
		<idno type="DOI">10.1152/ajpendo.00409.2002</idno>
		<idno type="PMID">12700160</idno>
		<ptr type="open-access" target="http://pdfs.semanticscholar.org/a022/a41d9e381de2a2828edcae90955faa216ef0.pdf" />
	</analytic>
	<monogr>
		<title level="j">American Journal of Physiology-Endocrinology and Metabolism</title>
		<title level="j" type="abbrev">American Journal of Physiology-Endocrinology and Metabolism</title>
		<idno type="ISSN">0193-1849</idno>
		<idno type="ISSNe">1522-1555</idno>
		<imprint>
			<biblScope unit="volume">285</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="E272" to="E279" />
			<date type="published" when="2003-08" />
			<publisher>American Physiological Society</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b37">
	<analytic>
		<title level="a" type="main">Dehydroepiandrosterone Affects the Expression of Multiple Genes in Rat Liver Including 11beta -Hydroxysteroid Dehydrogenase Type 1: A cDNA Array Analysis</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><surname>Gu</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><forename type="middle">L</forename><surname>Ripp</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">R</forename><forename type="middle">A</forename><surname>Prough</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">T</forename><forename type="middle">E</forename><surname>Geoghegan</surname></persName>
		</author>
		<idno type="DOI">10.1124/mol.63.3.722</idno>
		<idno type="PMID">12606783</idno>
		<ptr type="open-access" target="http://pdfs.semanticscholar.org/053a/fea33d1652ec75ad1738fd24c9537defad8c.pdf" />
	</analytic>
	<monogr>
		<title level="j">Molecular Pharmacology</title>
		<idno type="ISSN">0026-895X</idno>
		<imprint>
			<biblScope unit="volume">63</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="722" to="731" />
			<date type="published" when="2003-03-01" />
			<publisher>American Society for Pharmacology &amp; Experimental Therapeutics (ASPET)</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b38">
	<analytic>
		<title level="a" type="main">Body fat distribution and coronary heart disease mortality in subjects with impaired glucose tolerance or diabetes mellitus: the Paris Prospective Study, 15-year follow-up</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">A</forename><surname>Fontbonne</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">N</forename><surname>Thibult</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">E</forename><surname>Eschwège</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">P</forename><surname>Ducimetière</surname></persName>
		</author>
		<idno type="DOI">10.1007/bf02342445</idno>
		<idno type="PMID">1521729</idno>
		<idno type="ark">ark:/67375/1BB-B8P2ZLJ4-6</idno>
		<idno type="istexId">57D651A3F09AAE69E230778C3EE62EA97679A93D</idno>
		<ptr type="open-access" target="https://link.springer.com/content/pdf/10.1007%2FBF02342445.pdf" />
	</analytic>
	<monogr>
		<title level="j">Diabetologia</title>
		<title level="j" type="abbrev">Diabetologia</title>
		<idno type="ISSN">0012-186X</idno>
		<idno type="ISSNe">1432-0428</idno>
		<imprint>
			<biblScope unit="volume">35</biblScope>
			<biblScope unit="issue">5</biblScope>
			<biblScope unit="page" from="464" to="468" />
			<date type="published" when="1992-05" />
			<publisher>Springer Nature</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b39">
	<analytic>
		<title level="a" type="main">The Identification of 5 -Reductase-2 and 17 -Hydroxysteroid Dehydrogenase-3 Gene Defects in Male Pseudohermaphrodites from a Turkish Kindred</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><surname>Can</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Y</forename><forename type="middle">S</forename><surname>Zhu</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">L</forename><forename type="middle">Q</forename><surname>Cai</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Q</forename><surname>Ling</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><forename type="middle">D</forename><surname>Katz</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><surname>Akgun</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">C</forename><forename type="middle">H</forename><surname>Shackleton</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><surname>Imperato-Mcginley</surname></persName>
		</author>
		<idno type="DOI">10.1210/jc.83.2.560</idno>
		<idno type="PMID">9467575</idno>
	</analytic>
	<monogr>
		<title level="j">Journal of Clinical Endocrinology &amp; Metabolism</title>
		<title level="j" type="abbrev">Journal of Clinical Endocrinology &amp; Metabolism</title>
		<idno type="ISSN">0021-972X</idno>
		<imprint>
			<biblScope unit="volume">83</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="560" to="569" />
			<date type="published" when="1998-02-01" />
			<publisher>The Endocrine Society</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b40">
	<analytic>
		<title level="a" type="main">Obesity and Gender Influence Cortisol Secretion and Metabolism in Man</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Ruth</forename><surname>Andrew</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">David</forename><forename type="middle">I W</forename><surname>Phillips</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Brian</forename><forename type="middle">R</forename><surname>Walker</surname></persName>
		</author>
		<idno type="DOI">10.1210/jcem.83.5.4951</idno>
		<idno type="PMID">9589697</idno>
		<ptr type="open-access" target="https://academic.oup.com/jcem/article-pdf/83/5/1806/9232093/jcem1806.pdf" />
	</analytic>
	<monogr>
		<title level="j">The Journal of Clinical Endocrinology &amp; Metabolism</title>
		<title level="j" type="abbrev">The Journal of Clinical Endocrinology &amp; Metabolism</title>
		<idno type="ISSN">0021-972X</idno>
		<idno type="ISSNe">1945-7197</idno>
		<imprint>
			<biblScope unit="volume">83</biblScope>
			<biblScope unit="issue">5</biblScope>
			<biblScope unit="page" from="1806" to="1806" />
			<date type="published" when="1998-05" />
			<publisher>The Endocrine Society</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b41">
	<analytic>
		<title level="a" type="main">Abnormal Cortisol Metabolism and Tissue Sensitivity to Cortisol in Patients with Glucose Intolerance</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Robert</forename><forename type="middle">C</forename><surname>Andrews</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Olive</forename><surname>Herlihy</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Dawn</forename><forename type="middle">E W</forename><surname>Livingstone</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Ruth</forename><surname>Andrew</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Brian</forename><forename type="middle">R</forename><surname>Walker</surname></persName>
		</author>
		<idno type="DOI">10.1210/jc.2002-020048</idno>
		<idno type="PMID">12466357</idno>
		<ptr type="open-access" target="https://academic.oup.com/jcem/article-pdf/87/12/5587/9043124/jcem5587.pdf" />
	</analytic>
	<monogr>
		<title level="j">The Journal of Clinical Endocrinology &amp; Metabolism</title>
		<title level="j" type="abbrev">The Journal of Clinical Endocrinology &amp; Metabolism</title>
		<idno type="ISSN">0021-972X</idno>
		<idno type="ISSNe">1945-7197</idno>
		<imprint>
			<biblScope unit="volume">87</biblScope>
			<biblScope unit="issue">12</biblScope>
			<biblScope unit="page" from="5587" to="5593" />
			<date type="published" when="2002-12" />
			<publisher>The Endocrine Society</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b42">
	<analytic>
		<title level="a" type="main">Dietary Macronutrient Content Alters Cortisol Metabolism Independently of Body Weight Changes in Obese Men</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Roland</forename><forename type="middle">H</forename><surname>Stimson</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Alexandra</forename><forename type="middle">M</forename><surname>Johnstone</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Natalie</forename><forename type="middle">Z M</forename><surname>Homer</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Deborah</forename><forename type="middle">J</forename><surname>Wake</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Nicholas</forename><forename type="middle">M</forename><surname>Morton</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Ruth</forename><surname>Andrew</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Gerald</forename><forename type="middle">E</forename><surname>Lobley</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Brian</forename><forename type="middle">R</forename><surname>Walker</surname></persName>
		</author>
		<idno type="DOI">10.1210/jc.2007-0692</idno>
		<idno type="PMID">17785367</idno>
		<ptr type="open-access" target="https://academic.oup.com/jcem/article-pdf/92/11/4480/9055460/jcem4480.pdf" />
	</analytic>
	<monogr>
		<title level="j">The Journal of Clinical Endocrinology &amp; Metabolism</title>
		<title level="j" type="abbrev">The Journal of Clinical Endocrinology &amp; Metabolism</title>
		<idno type="ISSN">0021-972X</idno>
		<idno type="ISSNe">1945-7197</idno>
		<imprint>
			<biblScope unit="volume">92</biblScope>
			<biblScope unit="issue">11</biblScope>
			<biblScope unit="page" from="4480" to="4484" />
			<date type="published" when="2007-11" />
			<publisher>The Endocrine Society</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b43">
	<analytic>
		<title level="a" type="main">Increased A-ring Reduction of Glucocorticoids in Obese Zucker Rats: Effects of Insulin Sensitization</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Dawn</forename><forename type="middle">E W</forename><surname>Livingstone</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Kerry</forename><forename type="middle">J</forename><surname>Mcinnes</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Brian</forename><forename type="middle">R</forename><surname>Walker</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Ruth</forename><surname>Andrew</surname></persName>
		</author>
		<idno type="DOI">10.1038/oby.2005.186</idno>
		<idno type="PMID">16222053</idno>
	</analytic>
	<monogr>
		<title level="j">Obesity Research</title>
		<idno type="ISSN">1071-7323</idno>
		<imprint>
			<biblScope unit="volume">13</biblScope>
			<biblScope unit="issue">9</biblScope>
			<biblScope unit="page" from="1523" to="1526" />
			<date type="published" when="2005-09" />
			<publisher>Wiley</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b44">
	<analytic>
		<title level="a" type="main">Reduced Glucocorticoid Production Rate, Decreased 5 -Reductase Activity, and Adipose Tissue Insulin Sensitization After Weight Loss</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><forename type="middle">W</forename><surname>Tomlinson</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><surname>Finney</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">B</forename><forename type="middle">A</forename><surname>Hughes</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><forename type="middle">V</forename><surname>Hughes</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">P</forename><forename type="middle">M</forename><surname>Stewart</surname></persName>
		</author>
		<idno type="DOI">10.2337/db08-0094</idno>
		<idno type="PMID">18340018</idno>
		<ptr type="open-access" target="http://diabetes.diabetesjournals.org/content/diabetes/57/6/1536.full.pdf" />
	</analytic>
	<monogr>
		<title level="j">Diabetes</title>
		<title level="j" type="abbrev">Diabetes</title>
		<idno type="ISSN">0012-1797</idno>
		<idno type="ISSNe">1939-327X</idno>
		<imprint>
			<biblScope unit="volume">57</biblScope>
			<biblScope unit="issue">6</biblScope>
			<biblScope unit="page" from="1536" to="1543" />
			<date type="published" when="2008-03-13" />
			<publisher>American Diabetes Association</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b45">
	<analytic>
		<title level="a" type="main">5 α-reductase activity in polycystic ovary syndrome</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">P</forename><forename type="middle">M</forename><surname>Stewart</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Crw</forename><forename type="middle">R W</forename><surname>Edwards</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Chl</forename><forename type="middle">H L</forename><surname>Shackleton</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">G</forename><forename type="middle">H</forename><surname>Beastall</surname></persName>
		</author>
		<idno type="DOI">10.1016/0140-6736(90)90664-q</idno>
		<idno type="PMID">1968168</idno>
		<idno type="PII">0140-6736(90)90664-Q</idno>
		<idno type="ark">ark:/67375/6H6-7L54F3VJ-4</idno>
		<idno type="istexId">60A394CDE326BD8D0EFC1DA305C4F2755E5469FA</idno>
	</analytic>
	<monogr>
		<title level="j">The Lancet</title>
		<title level="j" type="abbrev">The Lancet</title>
		<idno type="ISSN">0140-6736</idno>
		<imprint>
			<biblScope unit="volume">335</biblScope>
			<biblScope unit="issue">8687</biblScope>
			<biblScope unit="page" from="431" to="433" />
			<date type="published" when="1990-02" />
			<publisher>Elsevier BV</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b46">
	<analytic>
		<title level="a" type="main">Altered Cortisol Metabolism in Polycystic Ovary Syndrome: Insulin Enhances 5α-Reduction But Not the Elevated Adrenal Steroid Production Rates</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Tasoula</forename><surname>Tsilchorozidou</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">John</forename><forename type="middle">W</forename><surname>Honour</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Gerard</forename><forename type="middle">S</forename><surname>Conway</surname></persName>
		</author>
		<idno type="DOI">10.1210/jc.2003-030240</idno>
		<idno type="PMID">14671189</idno>
		<ptr type="open-access" target="https://academic.oup.com/jcem/article-pdf/88/12/5907/9063244/jcem5907.pdf" />
	</analytic>
	<monogr>
		<title level="j">The Journal of Clinical Endocrinology &amp; Metabolism</title>
		<title level="j" type="abbrev">The Journal of Clinical Endocrinology &amp; Metabolism</title>
		<idno type="ISSN">0021-972X</idno>
		<idno type="ISSNe">1945-7197</idno>
		<imprint>
			<biblScope unit="volume">88</biblScope>
			<biblScope unit="issue">12</biblScope>
			<biblScope unit="page" from="5907" to="5913" />
			<date type="published" when="2003-12" />
			<publisher>The Endocrine Society</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b47">
	<analytic>
		<title level="a" type="main">Drug Insight: 5α-reductase inhibitors for the treatment of benign prostatic hyperplasia</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Michael</forename><surname>Marberger</surname></persName>
		</author>
		<idno type="DOI">10.1038/ncpuro0577</idno>
		<idno type="PMID">16964191</idno>
	</analytic>
	<monogr>
		<title level="j">Nature Clinical Practice Urology</title>
		<title level="j" type="abbrev">Nat Rev Urol</title>
		<idno type="ISSN">1743-4270</idno>
		<idno type="ISSNe">1743-4289</idno>
		<imprint>
			<biblScope unit="volume">3</biblScope>
			<biblScope unit="issue">9</biblScope>
			<biblScope unit="page" from="495" to="503" />
			<date type="published" when="2006-09" />
			<publisher>Springer Nature</publisher>
		</imprint>
	</monogr>
</biblStruct>

				</listBibl>
			</div>
		</back>
	</text>
</TEI>
